Prism AI
  • 30,000 reports
  • 1.2 million data points
  • One conversation
Explore with AI
Gastric Cancer Drug-Level Market Intelligence, Commercial Forecasting, Estimations & Portfolio Report

Gastric Cancer Drug-Level Market Intelligence, Commercial Forecasting, Estimations & Portfolio Analysis, 2021-2033

Table of Contents

Chapter 1. Pembrolizumab (Keytruda) Market Estimates & Forecast 2021-2033 (USD Mn)

  • 1.1. Drug Information
  • 1.1.1. Drug Information
  • 1.1.2. Drug Patent Analysis
  • 1.2. Drug Estimates By Region
  • 1.2.1. North America
  • 1.2.1.1. Drug Insights
  • 1.2.1.2. Drug Estimates By Route of Administration
  • 1.2.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.1.3. Drug Estimates By Type
  • 1.2.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.1.4. Drug Estimates By Country
  • 1.2.1.4.1. U.S.
  • 1.2.1.4.1.1. Drug Insight
  • 1.2.1.4.1.2. Drug Estimates By Route of Administration
  • 1.2.1.4.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.1.4.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.1.4.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.1.4.1.3. Drug Estimates By Type
  • 1.2.1.4.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.1.4.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.1.4.2. Canada
  • 1.2.1.4.2.1. Drug Insights
  • 1.2.1.4.2.2. Drug Estimates By Route of Administration
  • 1.2.1.4.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.1.4.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.1.4.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.1.4.2.3. Drug Estimates By Type
  • 1.2.1.4.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.1.4.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.1.4.3. Mexico
  • 1.2.1.4.3.1. Drug Insights
  • 1.2.1.4.3.2. Drug Estimates By Route of Administration
  • 1.2.1.4.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.1.4.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.1.4.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.1.4.3.3. Drug Estimates By Type
  • 1.2.1.4.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.1.4.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.2. Europe
  • 1.2.2.1. UK
  • 1.2.2.1.1. Drug Insights
  • 1.2.2.1.2. Drug Estimates By Route of Administration
  • 1.2.2.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.2.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.2.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.2.1.3. Drug Estimates By Type
  • 1.2.2.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.2.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.2.2. Germany
  • 1.2.2.2.1. Drug Insights
  • 1.2.2.2.2. Drug Estimates By Route of Administration
  • 1.2.2.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.2.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.2.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.2.2.3. Drug Estimates By Type
  • 1.2.2.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.2.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.2.3. France
  • 1.2.2.3.1. Drug Insights
  • 1.2.2.3.2. Drug Estimates By Route of Administration
  • 1.2.2.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.2.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.2.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.2.3.3. Drug Estimates By Type
  • 1.2.2.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.2.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.2.4. Italy
  • 1.2.2.4.1. Drug Insights
  • 1.2.2.4.2. Drug Estimates By Route of Administration
  • 1.2.2.4.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.2.4.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.2.4.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.2.4.3. Drug Estimates By Type
  • 1.2.2.4.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.2.4.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.2.5. Spain
  • 1.2.2.5.1. Drug Insights
  • 1.2.2.5.2. Drug Estimates By Route of Administration
  • 1.2.2.5.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.2.5.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.2.5.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.2.5.3. Drug Estimates By Type
  • 1.2.2.5.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.2.5.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.2.6. Denmark
  • 1.2.2.6.1. Drug Insights
  • 1.2.2.6.2. Drug Estimates By Route of Administration
  • 1.2.2.6.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.2.6.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.2.6.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.2.6.3. Drug Estimates By Type
  • 1.2.2.6.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.2.6.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.2.7. Sweden
  • 1.2.2.7.1. Drug Insights
  • 1.2.2.7.2. Drug Estimates By Route of Administration
  • 1.2.2.7.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.2.7.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.2.7.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.2.7.3. Drug Estimates By Type
  • 1.2.2.7.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.2.7.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.2.8. Norway
  • 1.2.2.8.1. Drug Insights
  • 1.2.2.8.2. Drug Estimates By Route of Administration
  • 1.2.2.8.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.2.8.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.2.8.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.2.8.3. Drug Estimates By Type
  • 1.2.2.8.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.2.8.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.2.9. Rest of Europe
  • 1.2.2.9.1. Drug Insights
  • 1.2.2.9.2. Drug Estimates By Route of Administration
  • 1.2.2.9.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.2.9.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.2.9.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.2.9.3. Drug Estimates By Type
  • 1.2.2.9.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.2.9.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.3. Asia Pacific
  • 1.2.3.1. Japan
  • 1.2.3.1.1. Drug Insights
  • 1.2.3.1.2. Drug Estimates By Route of Administration
  • 1.2.3.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.3.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.3.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.3.1.3. Drug Estimates By Type
  • 1.2.3.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.3.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.3.2. China
  • 1.2.3.2.1. Drug Insights
  • 1.2.3.2.2. Drug Estimates By Route of Administration
  • 1.2.3.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.3.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.3.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.3.2.3. Drug Estimates By Type
  • 1.2.3.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.3.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.3.3. India
  • 1.2.3.3.1. Drug Insights
  • 1.2.3.3.2. Drug Estimates By Route of Administration
  • 1.2.3.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.3.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.3.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.3.3.3. Drug Estimates By Type
  • 1.2.3.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.3.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.3.4. South Korea
  • 1.2.3.4.1. Drug Insights
  • 1.2.3.4.2. Drug Estimates By Route of Administration
  • 1.2.3.4.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.3.4.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.3.4.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.3.4.3. Drug Estimates By Type
  • 1.2.3.4.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.3.4.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.3.5. Australia
  • 1.2.3.5.1. Drug Insights
  • 1.2.3.5.2. Drug Estimates By Route of Administration
  • 1.2.3.5.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.3.5.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.3.5.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.3.5.3. Drug Estimates By Type
  • 1.2.3.5.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.3.5.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.3.6. Thailand
  • 1.2.3.6.1. Drug Insights
  • 1.2.3.6.2. Drug Estimates By Route of Administration
  • 1.2.3.6.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.3.6.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.3.6.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.3.6.3. Drug Estimates By Type
  • 1.2.3.6.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.3.6.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.3.7. Rest of APAC
  • 1.2.3.7.1. Drug Insights
  • 1.2.3.7.2. Drug Estimates By Route of Administration
  • 1.2.3.7.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.3.7.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.3.7.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.3.7.3. Drug Estimates By Type
  • 1.2.3.7.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.3.7.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.4. Latin America
  • 1.2.4.1. Brazil
  • 1.2.4.1.1. Drug Insights
  • 1.2.4.1.2. Drug Estimates By Route of Administration
  • 1.2.4.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.4.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.4.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.4.1.3. Drug Estimates By Type
  • 1.2.4.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.4.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.4.2. Argentina
  • 1.2.4.2.1. Drug Insights
  • 1.2.4.2.2. Drug Estimates By Route of Administration
  • 1.2.4.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.4.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.4.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.4.2.3. Drug Estimates By Type
  • 1.2.4.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.4.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.4.3. Rest of Latin America
  • 1.2.4.3.1. Drug Insights
  • 1.2.4.3.2. Drug Estimates By Route of Administration
  • 1.2.4.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.4.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.4.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.4.3.3. Drug Estimates By Type
  • 1.2.4.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.4.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.5. Middle East & Africa
  • 1.2.5.1. Saudi Arabia
  • 1.2.5.1.1. Drug Insights
  • 1.2.5.1.2. Drug Estimates By Route of Administration
  • 1.2.5.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.5.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.5.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.5.1.3. Drug Estimates By Type
  • 1.2.5.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.5.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.5.2. UAE
  • 1.2.5.2.1. Drug Insights
  • 1.2.5.2.2. Drug Estimates By Route of Administration
  • 1.2.5.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.5.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.5.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.5.2.3. Drug Estimates By Type
  • 1.2.5.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.5.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.5.3. Kuwait
  • 1.2.5.3.1. Drug Insights
  • 1.2.5.3.2. Drug Estimates By Route of Administration
  • 1.2.5.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.5.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.5.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.5.3.3. Drug Estimates By Type
  • 1.2.5.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.5.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.5.4. Rest of Middle East & Africa
  • 1.2.5.4.1. Drug Insights
  • 1.2.5.4.2. Drug Estimates By Route of Administration
  • 1.2.5.4.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.5.4.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.5.4.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.5.4.3. Drug Estimates By Type
  • 1.2.5.4.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 1.2.5.4.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)

Chapter 2. Regorafenib (Stivarga) Market Estimates & Forecast 2021-2033 (USD Mn)

  • 2.1. Drug Information
  • 2.1.1. Drug Information
  • 2.1.2. Drug Patent Analysis
  • 2.2. Drug Estimates By Region
  • 2.2.1. North America
  • 2.2.1.1. Drug Insights
  • 2.2.1.2. Drug Estimates By Route of Administration
  • 2.2.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.1.3. Drug Estimates By Type
  • 2.2.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.1.4. Drug Estimates By Country
  • 2.2.1.4.1. U.S.
  • 2.2.1.4.1.1. Drug Insight
  • 2.2.1.4.1.2. Drug Estimates By Route of Administration
  • 2.2.1.4.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.1.4.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.1.4.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.1.4.1.3. Drug Estimates By Type
  • 2.2.1.4.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.1.4.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.1.4.2. Canada
  • 2.2.1.4.2.1. Drug Insights
  • 2.2.1.4.2.2. Drug Estimates By Route of Administration
  • 2.2.1.4.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.1.4.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.1.4.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.1.4.2.3. Drug Estimates By Type
  • 2.2.1.4.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.1.4.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.1.4.3. Mexico
  • 2.2.1.4.3.1. Drug Insights
  • 2.2.1.4.3.2. Drug Estimates By Route of Administration
  • 2.2.1.4.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.1.4.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.1.4.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.1.4.3.3. Drug Estimates By Type
  • 2.2.1.4.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.1.4.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.2. Europe
  • 2.2.2.1. UK
  • 2.2.2.1.1. Drug Insights
  • 2.2.2.1.2. Drug Estimates By Route of Administration
  • 2.2.2.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.2.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.2.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.2.1.3. Drug Estimates By Type
  • 2.2.2.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.2.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.2.2. Germany
  • 2.2.2.2.1. Drug Insights
  • 2.2.2.2.2. Drug Estimates By Route of Administration
  • 2.2.2.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.2.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.2.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.2.2.3. Drug Estimates By Type
  • 2.2.2.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.2.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.2.3. France
  • 2.2.2.3.1. Drug Insights
  • 2.2.2.3.2. Drug Estimates By Route of Administration
  • 2.2.2.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.2.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.2.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.2.3.3. Drug Estimates By Type
  • 2.2.2.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.2.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.2.4. Italy
  • 2.2.2.4.1. Drug Insights
  • 2.2.2.4.2. Drug Estimates By Route of Administration
  • 2.2.2.4.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.2.4.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.2.4.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.2.4.3. Drug Estimates By Type
  • 2.2.2.4.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.2.4.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.2.5. Spain
  • 2.2.2.5.1. Drug Insights
  • 2.2.2.5.2. Drug Estimates By Route of Administration
  • 2.2.2.5.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.2.5.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.2.5.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.2.5.3. Drug Estimates By Type
  • 2.2.2.5.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.2.5.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.2.6. Denmark
  • 2.2.2.6.1. Drug Insights
  • 2.2.2.6.2. Drug Estimates By Route of Administration
  • 2.2.2.6.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.2.6.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.2.6.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.2.6.3. Drug Estimates By Type
  • 2.2.2.6.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.2.6.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.2.7. Sweden
  • 2.2.2.7.1. Drug Insights
  • 2.2.2.7.2. Drug Estimates By Route of Administration
  • 2.2.2.7.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.2.7.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.2.7.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.2.7.3. Drug Estimates By Type
  • 2.2.2.7.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.2.7.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.2.8. Norway
  • 2.2.2.8.1. Drug Insights
  • 2.2.2.8.2. Drug Estimates By Route of Administration
  • 2.2.2.8.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.2.8.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.2.8.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.2.8.3. Drug Estimates By Type
  • 2.2.2.8.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.2.8.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.2.9. Rest of Europe
  • 2.2.2.9.1. Drug Insights
  • 2.2.2.9.2. Drug Estimates By Route of Administration
  • 2.2.2.9.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.2.9.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.2.9.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.2.9.3. Drug Estimates By Type
  • 2.2.2.9.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.2.9.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.3. Asia Pacific
  • 2.2.3.1. Japan
  • 2.2.3.1.1. Drug Insights
  • 2.2.3.1.2. Drug Estimates By Route of Administration
  • 2.2.3.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.3.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.3.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.3.1.3. Drug Estimates By Type
  • 2.2.3.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.3.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.3.2. China
  • 2.2.3.2.1. Drug Insights
  • 2.2.3.2.2. Drug Estimates By Route of Administration
  • 2.2.3.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.3.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.3.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.3.2.3. Drug Estimates By Type
  • 2.2.3.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.3.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.3.3. India
  • 2.2.3.3.1. Drug Insights
  • 2.2.3.3.2. Drug Estimates By Route of Administration
  • 2.2.3.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.3.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.3.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.3.3.3. Drug Estimates By Type
  • 2.2.3.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.3.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.3.4. South Korea
  • 2.2.3.4.1. Drug Insights
  • 2.2.3.4.2. Drug Estimates By Route of Administration
  • 2.2.3.4.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.3.4.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.3.4.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.3.4.3. Drug Estimates By Type
  • 2.2.3.4.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.3.4.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.3.5. Australia
  • 2.2.3.5.1. Drug Insights
  • 2.2.3.5.2. Drug Estimates By Route of Administration
  • 2.2.3.5.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.3.5.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.3.5.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.3.5.3. Drug Estimates By Type
  • 2.2.3.5.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.3.5.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.3.6. Thailand
  • 2.2.3.6.1. Drug Insights
  • 2.2.3.6.2. Drug Estimates By Route of Administration
  • 2.2.3.6.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.3.6.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.3.6.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.3.6.3. Drug Estimates By Type
  • 2.2.3.6.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.3.6.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.3.7. Rest of APAC
  • 2.2.3.7.1. Drug Insights
  • 2.2.3.7.2. Drug Estimates By Route of Administration
  • 2.2.3.7.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.3.7.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.3.7.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.3.7.3. Drug Estimates By Type
  • 2.2.3.7.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.3.7.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.4. Latin America
  • 2.2.4.1. Brazil
  • 2.2.4.1.1. Drug Insights
  • 2.2.4.1.2. Drug Estimates By Route of Administration
  • 2.2.4.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.4.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.4.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.4.1.3. Drug Estimates By Type
  • 2.2.4.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.4.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.4.2. Argentina
  • 2.2.4.2.1. Drug Insights
  • 2.2.4.2.2. Drug Estimates By Route of Administration
  • 2.2.4.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.4.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.4.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.4.2.3. Drug Estimates By Type
  • 2.2.4.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.4.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.4.3. Rest of Latin America
  • 2.2.4.3.1. Drug Insights
  • 2.2.4.3.2. Drug Estimates By Route of Administration
  • 2.2.4.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.4.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.4.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.4.3.3. Drug Estimates By Type
  • 2.2.4.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.4.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.5. Middle East & Africa
  • 2.2.5.1. Saudi Arabia
  • 2.2.5.1.1. Drug Insights
  • 2.2.5.1.2. Drug Estimates By Route of Administration
  • 2.2.5.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.5.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.5.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.5.1.3. Drug Estimates By Type
  • 2.2.5.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.5.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.5.2. UAE
  • 2.2.5.2.1. Drug Insights
  • 2.2.5.2.2. Drug Estimates By Route of Administration
  • 2.2.5.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.5.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.5.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.5.2.3. Drug Estimates By Type
  • 2.2.5.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.5.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.5.3. Kuwait
  • 2.2.5.3.1. Drug Insights
  • 2.2.5.3.2. Drug Estimates By Route of Administration
  • 2.2.5.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.5.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.5.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.5.3.3. Drug Estimates By Type
  • 2.2.5.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.5.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.5.4. Rest of Middle East & Africa
  • 2.2.5.4.1. Drug Insights
  • 2.2.5.4.2. Drug Estimates By Route of Administration
  • 2.2.5.4.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.5.4.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.5.4.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.5.4.3. Drug Estimates By Type
  • 2.2.5.4.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 2.2.5.4.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)

Chapter 3. Capecitabine (Xeloda) Market Estimates & Forecast 2021-2033 (USD Mn)

  • 3.1. Drug Information
  • 3.1.1. Drug Information
  • 3.1.2. Drug Patent Analysis
  • 3.2. Drug Estimates By Region
  • 3.2.1. North America
  • 3.2.1.1. Drug Insights
  • 3.2.1.2. Drug Estimates By Route of Administration
  • 3.2.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.1.3. Drug Estimates By Type
  • 3.2.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.1.4. Drug Estimates By Country
  • 3.2.1.4.1. U.S.
  • 3.2.1.4.1.1. Drug Insight
  • 3.2.1.4.1.2. Drug Estimates By Route of Administration
  • 3.2.1.4.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.1.4.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.1.4.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.1.4.1.3. Drug Estimates By Type
  • 3.2.1.4.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.1.4.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.1.4.2. Canada
  • 3.2.1.4.2.1. Drug Insights
  • 3.2.1.4.2.2. Drug Estimates By Route of Administration
  • 3.2.1.4.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.1.4.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.1.4.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.1.4.2.3. Drug Estimates By Type
  • 3.2.1.4.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.1.4.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.1.4.3. Mexico
  • 3.2.1.4.3.1. Drug Insights
  • 3.2.1.4.3.2. Drug Estimates By Route of Administration
  • 3.2.1.4.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.1.4.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.1.4.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.1.4.3.3. Drug Estimates By Type
  • 3.2.1.4.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.1.4.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.2. Europe
  • 3.2.2.1. UK
  • 3.2.2.1.1. Drug Insights
  • 3.2.2.1.2. Drug Estimates By Route of Administration
  • 3.2.2.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.2.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.2.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.2.1.3. Drug Estimates By Type
  • 3.2.2.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.2.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.2.2. Germany
  • 3.2.2.2.1. Drug Insights
  • 3.2.2.2.2. Drug Estimates By Route of Administration
  • 3.2.2.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.2.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.2.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.2.2.3. Drug Estimates By Type
  • 3.2.2.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.2.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.2.3. France
  • 3.2.2.3.1. Drug Insights
  • 3.2.2.3.2. Drug Estimates By Route of Administration
  • 3.2.2.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.2.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.2.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.2.3.3. Drug Estimates By Type
  • 3.2.2.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.2.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.2.4. Italy
  • 3.2.2.4.1. Drug Insights
  • 3.2.2.4.2. Drug Estimates By Route of Administration
  • 3.2.2.4.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.2.4.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.2.4.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.2.4.3. Drug Estimates By Type
  • 3.2.2.4.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.2.4.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.2.5. Spain
  • 3.2.2.5.1. Drug Insights
  • 3.2.2.5.2. Drug Estimates By Route of Administration
  • 3.2.2.5.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.2.5.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.2.5.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.2.5.3. Drug Estimates By Type
  • 3.2.2.5.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.2.5.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.2.6. Denmark
  • 3.2.2.6.1. Drug Insights
  • 3.2.2.6.2. Drug Estimates By Route of Administration
  • 3.2.2.6.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.2.6.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.2.6.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.2.6.3. Drug Estimates By Type
  • 3.2.2.6.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.2.6.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.2.7. Sweden
  • 3.2.2.7.1. Drug Insights
  • 3.2.2.7.2. Drug Estimates By Route of Administration
  • 3.2.2.7.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.2.7.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.2.7.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.2.7.3. Drug Estimates By Type
  • 3.2.2.7.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.2.7.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.2.8. Norway
  • 3.2.2.8.1. Drug Insights
  • 3.2.2.8.2. Drug Estimates By Route of Administration
  • 3.2.2.8.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.2.8.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.2.8.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.2.8.3. Drug Estimates By Type
  • 3.2.2.8.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.2.8.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.2.9. Rest of Europe
  • 3.2.2.9.1. Drug Insights
  • 3.2.2.9.2. Drug Estimates By Route of Administration
  • 3.2.2.9.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.2.9.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.2.9.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.2.9.3. Drug Estimates By Type
  • 3.2.2.9.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.2.9.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.3. Asia Pacific
  • 3.2.3.1. Japan
  • 3.2.3.1.1. Drug Insights
  • 3.2.3.1.2. Drug Estimates By Route of Administration
  • 3.2.3.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.3.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.3.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.3.1.3. Drug Estimates By Type
  • 3.2.3.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.3.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.3.2. China
  • 3.2.3.2.1. Drug Insights
  • 3.2.3.2.2. Drug Estimates By Route of Administration
  • 3.2.3.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.3.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.3.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.3.2.3. Drug Estimates By Type
  • 3.2.3.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.3.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.3.3. India
  • 3.2.3.3.1. Drug Insights
  • 3.2.3.3.2. Drug Estimates By Route of Administration
  • 3.2.3.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.3.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.3.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.3.3.3. Drug Estimates By Type
  • 3.2.3.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.3.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.3.4. South Korea
  • 3.2.3.4.1. Drug Insights
  • 3.2.3.4.2. Drug Estimates By Route of Administration
  • 3.2.3.4.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.3.4.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.3.4.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.3.4.3. Drug Estimates By Type
  • 3.2.3.4.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.3.4.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.3.5. Australia
  • 3.2.3.5.1. Drug Insights
  • 3.2.3.5.2. Drug Estimates By Route of Administration
  • 3.2.3.5.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.3.5.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.3.5.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.3.5.3. Drug Estimates By Type
  • 3.2.3.5.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.3.5.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.3.6. Thailand
  • 3.2.3.6.1. Drug Insights
  • 3.2.3.6.2. Drug Estimates By Route of Administration
  • 3.2.3.6.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.3.6.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.3.6.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.3.6.3. Drug Estimates By Type
  • 3.2.3.6.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.3.6.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.3.7. Rest of APAC
  • 3.2.3.7.1. Drug Insights
  • 3.2.3.7.2. Drug Estimates By Route of Administration
  • 3.2.3.7.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.3.7.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.3.7.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.3.7.3. Drug Estimates By Type
  • 3.2.3.7.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.3.7.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.4. Latin America
  • 3.2.4.1. Brazil
  • 3.2.4.1.1. Drug Insights
  • 3.2.4.1.2. Drug Estimates By Route of Administration
  • 3.2.4.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.4.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.4.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.4.1.3. Drug Estimates By Type
  • 3.2.4.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.4.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.4.2. Argentina
  • 3.2.4.2.1. Drug Insights
  • 3.2.4.2.2. Drug Estimates By Route of Administration
  • 3.2.4.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.4.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.4.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.4.2.3. Drug Estimates By Type
  • 3.2.4.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.4.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.4.3. Rest of Latin America
  • 3.2.4.3.1. Drug Insights
  • 3.2.4.3.2. Drug Estimates By Route of Administration
  • 3.2.4.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.4.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.4.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.4.3.3. Drug Estimates By Type
  • 3.2.4.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.4.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.5. Middle East & Africa
  • 3.2.5.1. Saudi Arabia
  • 3.2.5.1.1. Drug Insights
  • 3.2.5.1.2. Drug Estimates By Route of Administration
  • 3.2.5.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.5.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.5.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.5.1.3. Drug Estimates By Type
  • 3.2.5.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.5.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.5.2. UAE
  • 3.2.5.2.1. Drug Insights
  • 3.2.5.2.2. Drug Estimates By Route of Administration
  • 3.2.5.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.5.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.5.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.5.2.3. Drug Estimates By Type
  • 3.2.5.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.5.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.5.3. Kuwait
  • 3.2.5.3.1. Drug Insights
  • 3.2.5.3.2. Drug Estimates By Route of Administration
  • 3.2.5.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.5.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.5.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.5.3.3. Drug Estimates By Type
  • 3.2.5.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.5.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.5.4. Rest of Middle East & Africa
  • 3.2.5.4.1. Drug Insights
  • 3.2.5.4.2. Drug Estimates By Route of Administration
  • 3.2.5.4.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.5.4.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.5.4.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.5.4.3. Drug Estimates By Type
  • 3.2.5.4.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 3.2.5.4.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)

Chapter 4. Ramucirumab (Cyramza) Market Estimates & Forecast 2021-2033 (USD Mn)

  • 4.1. Drug Information
  • 4.1.1. Drug Information
  • 4.1.2. Drug Patent Analysis
  • 4.2. Drug Estimates By Region
  • 4.2.1. North America
  • 4.2.1.1. Drug Insights
  • 4.2.1.2. Drug Estimates By Route of Administration
  • 4.2.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.1.3. Drug Estimates By Type
  • 4.2.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.1.4. Drug Estimates By Country
  • 4.2.1.4.1. U.S.
  • 4.2.1.4.1.1. Drug Insight
  • 4.2.1.4.1.2. Drug Estimates By Route of Administration
  • 4.2.1.4.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.1.4.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.1.4.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.1.4.1.3. Drug Estimates By Type
  • 4.2.1.4.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.1.4.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.1.4.2. Canada
  • 4.2.1.4.2.1. Drug Insights
  • 4.2.1.4.2.2. Drug Estimates By Route of Administration
  • 4.2.1.4.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.1.4.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.1.4.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.1.4.2.3. Drug Estimates By Type
  • 4.2.1.4.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.1.4.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.1.4.3. Mexico
  • 4.2.1.4.3.1. Drug Insights
  • 4.2.1.4.3.2. Drug Estimates By Route of Administration
  • 4.2.1.4.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.1.4.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.1.4.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.1.4.3.3. Drug Estimates By Type
  • 4.2.1.4.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.1.4.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.2. Europe
  • 4.2.2.1. UK
  • 4.2.2.1.1. Drug Insights
  • 4.2.2.1.2. Drug Estimates By Route of Administration
  • 4.2.2.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.2.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.2.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.2.1.3. Drug Estimates By Type
  • 4.2.2.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.2.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.2.2. Germany
  • 4.2.2.2.1. Drug Insights
  • 4.2.2.2.2. Drug Estimates By Route of Administration
  • 4.2.2.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.2.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.2.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.2.2.3. Drug Estimates By Type
  • 4.2.2.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.2.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.2.3. France
  • 4.2.2.3.1. Drug Insights
  • 4.2.2.3.2. Drug Estimates By Route of Administration
  • 4.2.2.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.2.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.2.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.2.3.3. Drug Estimates By Type
  • 4.2.2.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.2.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.2.4. Italy
  • 4.2.2.4.1. Drug Insights
  • 4.2.2.4.2. Drug Estimates By Route of Administration
  • 4.2.2.4.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.2.4.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.2.4.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.2.4.3. Drug Estimates By Type
  • 4.2.2.4.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.2.4.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.2.5. Spain
  • 4.2.2.5.1. Drug Insights
  • 4.2.2.5.2. Drug Estimates By Route of Administration
  • 4.2.2.5.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.2.5.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.2.5.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.2.5.3. Drug Estimates By Type
  • 4.2.2.5.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.2.5.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.2.6. Denmark
  • 4.2.2.6.1. Drug Insights
  • 4.2.2.6.2. Drug Estimates By Route of Administration
  • 4.2.2.6.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.2.6.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.2.6.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.2.6.3. Drug Estimates By Type
  • 4.2.2.6.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.2.6.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.2.7. Sweden
  • 4.2.2.7.1. Drug Insights
  • 4.2.2.7.2. Drug Estimates By Route of Administration
  • 4.2.2.7.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.2.7.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.2.7.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.2.7.3. Drug Estimates By Type
  • 4.2.2.7.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.2.7.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.2.8. Norway
  • 4.2.2.8.1. Drug Insights
  • 4.2.2.8.2. Drug Estimates By Route of Administration
  • 4.2.2.8.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.2.8.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.2.8.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.2.8.3. Drug Estimates By Type
  • 4.2.2.8.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.2.8.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.2.9. Rest of Europe
  • 4.2.2.9.1. Drug Insights
  • 4.2.2.9.2. Drug Estimates By Route of Administration
  • 4.2.2.9.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.2.9.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.2.9.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.2.9.3. Drug Estimates By Type
  • 4.2.2.9.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.2.9.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.3. Asia Pacific
  • 4.2.3.1. Japan
  • 4.2.3.1.1. Drug Insights
  • 4.2.3.1.2. Drug Estimates By Route of Administration
  • 4.2.3.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.3.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.3.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.3.1.3. Drug Estimates By Type
  • 4.2.3.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.3.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.3.2. China
  • 4.2.3.2.1. Drug Insights
  • 4.2.3.2.2. Drug Estimates By Route of Administration
  • 4.2.3.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.3.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.3.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.3.2.3. Drug Estimates By Type
  • 4.2.3.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.3.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.3.3. India
  • 4.2.3.3.1. Drug Insights
  • 4.2.3.3.2. Drug Estimates By Route of Administration
  • 4.2.3.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.3.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.3.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.3.3.3. Drug Estimates By Type
  • 4.2.3.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.3.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.3.4. South Korea
  • 4.2.3.4.1. Drug Insights
  • 4.2.3.4.2. Drug Estimates By Route of Administration
  • 4.2.3.4.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.3.4.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.3.4.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.3.4.3. Drug Estimates By Type
  • 4.2.3.4.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.3.4.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.3.5. Australia
  • 4.2.3.5.1. Drug Insights
  • 4.2.3.5.2. Drug Estimates By Route of Administration
  • 4.2.3.5.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.3.5.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.3.5.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.3.5.3. Drug Estimates By Type
  • 4.2.3.5.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.3.5.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.3.6. Thailand
  • 4.2.3.6.1. Drug Insights
  • 4.2.3.6.2. Drug Estimates By Route of Administration
  • 4.2.3.6.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.3.6.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.3.6.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.3.6.3. Drug Estimates By Type
  • 4.2.3.6.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.3.6.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.3.7. Rest of APAC
  • 4.2.3.7.1. Drug Insights
  • 4.2.3.7.2. Drug Estimates By Route of Administration
  • 4.2.3.7.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.3.7.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.3.7.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.3.7.3. Drug Estimates By Type
  • 4.2.3.7.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.3.7.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.4. Latin America
  • 4.2.4.1. Brazil
  • 4.2.4.1.1. Drug Insights
  • 4.2.4.1.2. Drug Estimates By Route of Administration
  • 4.2.4.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.4.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.4.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.4.1.3. Drug Estimates By Type
  • 4.2.4.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.4.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.4.2. Argentina
  • 4.2.4.2.1. Drug Insights
  • 4.2.4.2.2. Drug Estimates By Route of Administration
  • 4.2.4.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.4.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.4.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.4.2.3. Drug Estimates By Type
  • 4.2.4.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.4.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.4.3. Rest of Latin America
  • 4.2.4.3.1. Drug Insights
  • 4.2.4.3.2. Drug Estimates By Route of Administration
  • 4.2.4.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.4.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.4.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.4.3.3. Drug Estimates By Type
  • 4.2.4.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.4.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.5. Middle East & Africa
  • 4.2.5.1. Saudi Arabia
  • 4.2.5.1.1. Drug Insights
  • 4.2.5.1.2. Drug Estimates By Route of Administration
  • 4.2.5.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.5.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.5.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.5.1.3. Drug Estimates By Type
  • 4.2.5.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.5.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.5.2. UAE
  • 4.2.5.2.1. Drug Insights
  • 4.2.5.2.2. Drug Estimates By Route of Administration
  • 4.2.5.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.5.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.5.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.5.2.3. Drug Estimates By Type
  • 4.2.5.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.5.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.5.3. Kuwait
  • 4.2.5.3.1. Drug Insights
  • 4.2.5.3.2. Drug Estimates By Route of Administration
  • 4.2.5.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.5.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.5.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.5.3.3. Drug Estimates By Type
  • 4.2.5.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.5.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.5.4. Rest of Middle East & Africa
  • 4.2.5.4.1. Drug Insights
  • 4.2.5.4.2. Drug Estimates By Route of Administration
  • 4.2.5.4.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.5.4.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.5.4.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.5.4.3. Drug Estimates By Type
  • 4.2.5.4.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 4.2.5.4.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)

Chapter 5. Trastuzumab deruxtecan (Enhertu) Market Estimates & Forecast 2021-2033 (USD Mn)

  • 5.1. Drug Information
  • 5.1.1. Drug Information
  • 5.1.2. Drug Patent Analysis
  • 5.2. Drug Estimates By Region
  • 5.2.1. North America
  • 5.2.1.1. Drug Insights
  • 5.2.1.2. Drug Estimates By Route of Administration
  • 5.2.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.1.3. Drug Estimates By Type
  • 5.2.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.1.4. Drug Estimates By Country
  • 5.2.1.4.1. U.S.
  • 5.2.1.4.1.1. Drug Insight
  • 5.2.1.4.1.2. Drug Estimates By Route of Administration
  • 5.2.1.4.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.1.4.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.1.4.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.1.4.1.3. Drug Estimates By Type
  • 5.2.1.4.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.1.4.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.1.4.2. Canada
  • 5.2.1.4.2.1. Drug Insights
  • 5.2.1.4.2.2. Drug Estimates By Route of Administration
  • 5.2.1.4.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.1.4.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.1.4.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.1.4.2.3. Drug Estimates By Type
  • 5.2.1.4.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.1.4.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.1.4.3. Mexico
  • 5.2.1.4.3.1. Drug Insights
  • 5.2.1.4.3.2. Drug Estimates By Route of Administration
  • 5.2.1.4.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.1.4.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.1.4.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.1.4.3.3. Drug Estimates By Type
  • 5.2.1.4.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.1.4.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.2. Europe
  • 5.2.2.1. UK
  • 5.2.2.1.1. Drug Insights
  • 5.2.2.1.2. Drug Estimates By Route of Administration
  • 5.2.2.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.2.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.2.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.2.1.3. Drug Estimates By Type
  • 5.2.2.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.2.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.2.2. Germany
  • 5.2.2.2.1. Drug Insights
  • 5.2.2.2.2. Drug Estimates By Route of Administration
  • 5.2.2.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.2.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.2.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.2.2.3. Drug Estimates By Type
  • 5.2.2.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.2.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.2.3. France
  • 5.2.2.3.1. Drug Insights
  • 5.2.2.3.2. Drug Estimates By Route of Administration
  • 5.2.2.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.2.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.2.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.2.3.3. Drug Estimates By Type
  • 5.2.2.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.2.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.2.4. Italy
  • 5.2.2.4.1. Drug Insights
  • 5.2.2.4.2. Drug Estimates By Route of Administration
  • 5.2.2.4.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.2.4.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.2.4.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.2.4.3. Drug Estimates By Type
  • 5.2.2.4.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.2.4.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.2.5. Spain
  • 5.2.2.5.1. Drug Insights
  • 5.2.2.5.2. Drug Estimates By Route of Administration
  • 5.2.2.5.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.2.5.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.2.5.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.2.5.3. Drug Estimates By Type
  • 5.2.2.5.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.2.5.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.2.6. Denmark
  • 5.2.2.6.1. Drug Insights
  • 5.2.2.6.2. Drug Estimates By Route of Administration
  • 5.2.2.6.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.2.6.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.2.6.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.2.6.3. Drug Estimates By Type
  • 5.2.2.6.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.2.6.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.2.7. Sweden
  • 5.2.2.7.1. Drug Insights
  • 5.2.2.7.2. Drug Estimates By Route of Administration
  • 5.2.2.7.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.2.7.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.2.7.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.2.7.3. Drug Estimates By Type
  • 5.2.2.7.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.2.7.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.2.8. Norway
  • 5.2.2.8.1. Drug Insights
  • 5.2.2.8.2. Drug Estimates By Route of Administration
  • 5.2.2.8.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.2.8.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.2.8.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.2.8.3. Drug Estimates By Type
  • 5.2.2.8.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.2.8.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.2.9. Rest of Europe
  • 5.2.2.9.1. Drug Insights
  • 5.2.2.9.2. Drug Estimates By Route of Administration
  • 5.2.2.9.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.2.9.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.2.9.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.2.9.3. Drug Estimates By Type
  • 5.2.2.9.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.2.9.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.3. Asia Pacific
  • 5.2.3.1. Japan
  • 5.2.3.1.1. Drug Insights
  • 5.2.3.1.2. Drug Estimates By Route of Administration
  • 5.2.3.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.3.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.3.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.3.1.3. Drug Estimates By Type
  • 5.2.3.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.3.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.3.2. China
  • 5.2.3.2.1. Drug Insights
  • 5.2.3.2.2. Drug Estimates By Route of Administration
  • 5.2.3.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.3.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.3.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.3.2.3. Drug Estimates By Type
  • 5.2.3.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.3.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.3.3. India
  • 5.2.3.3.1. Drug Insights
  • 5.2.3.3.2. Drug Estimates By Route of Administration
  • 5.2.3.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.3.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.3.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.3.3.3. Drug Estimates By Type
  • 5.2.3.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.3.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.3.4. South Korea
  • 5.2.3.4.1. Drug Insights
  • 5.2.3.4.2. Drug Estimates By Route of Administration
  • 5.2.3.4.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.3.4.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.3.4.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.3.4.3. Drug Estimates By Type
  • 5.2.3.4.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.3.4.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.3.5. Australia
  • 5.2.3.5.1. Drug Insights
  • 5.2.3.5.2. Drug Estimates By Route of Administration
  • 5.2.3.5.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.3.5.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.3.5.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.3.5.3. Drug Estimates By Type
  • 5.2.3.5.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.3.5.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.3.6. Thailand
  • 5.2.3.6.1. Drug Insights
  • 5.2.3.6.2. Drug Estimates By Route of Administration
  • 5.2.3.6.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.3.6.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.3.6.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.3.6.3. Drug Estimates By Type
  • 5.2.3.6.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.3.6.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.3.7. Rest of APAC
  • 5.2.3.7.1. Drug Insights
  • 5.2.3.7.2. Drug Estimates By Route of Administration
  • 5.2.3.7.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.3.7.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.3.7.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.3.7.3. Drug Estimates By Type
  • 5.2.3.7.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.3.7.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.4. Latin America
  • 5.2.4.1. Brazil
  • 5.2.4.1.1. Drug Insights
  • 5.2.4.1.2. Drug Estimates By Route of Administration
  • 5.2.4.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.4.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.4.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.4.1.3. Drug Estimates By Type
  • 5.2.4.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.4.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.4.2. Argentina
  • 5.2.4.2.1. Drug Insights
  • 5.2.4.2.2. Drug Estimates By Route of Administration
  • 5.2.4.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.4.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.4.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.4.2.3. Drug Estimates By Type
  • 5.2.4.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.4.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.4.3. Rest of Latin America
  • 5.2.4.3.1. Drug Insights
  • 5.2.4.3.2. Drug Estimates By Route of Administration
  • 5.2.4.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.4.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.4.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.4.3.3. Drug Estimates By Type
  • 5.2.4.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.4.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.5. Middle East & Africa
  • 5.2.5.1. Saudi Arabia
  • 5.2.5.1.1. Drug Insights
  • 5.2.5.1.2. Drug Estimates By Route of Administration
  • 5.2.5.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.5.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.5.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.5.1.3. Drug Estimates By Type
  • 5.2.5.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.5.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.5.2. UAE
  • 5.2.5.2.1. Drug Insights
  • 5.2.5.2.2. Drug Estimates By Route of Administration
  • 5.2.5.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.5.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.5.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.5.2.3. Drug Estimates By Type
  • 5.2.5.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.5.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.5.3. Kuwait
  • 5.2.5.3.1. Drug Insights
  • 5.2.5.3.2. Drug Estimates By Route of Administration
  • 5.2.5.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.5.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.5.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.5.3.3. Drug Estimates By Type
  • 5.2.5.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.5.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.5.4. Rest of Middle East & Africa
  • 5.2.5.4.1. Drug Insights
  • 5.2.5.4.2. Drug Estimates By Route of Administration
  • 5.2.5.4.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.5.4.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.5.4.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.5.4.3. Drug Estimates By Type
  • 5.2.5.4.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 5.2.5.4.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)

Chapter 6. Imatinib (Gleevec) Market Estimates & Forecast 2021-2033 (USD Mn)

  • 6.1. Drug Information
  • 6.1.1. Drug Information
  • 6.1.2. Drug Patent Analysis
  • 6.2. Drug Estimates By Region
  • 6.2.1. North America
  • 6.2.1.1. Drug Insights
  • 6.2.1.2. Drug Estimates By Route of Administration
  • 6.2.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.1.3. Drug Estimates By Type
  • 6.2.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.1.4. Drug Estimates By Country
  • 6.2.1.4.1. U.S.
  • 6.2.1.4.1.1. Drug Insight
  • 6.2.1.4.1.2. Drug Estimates By Route of Administration
  • 6.2.1.4.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.1.4.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.1.4.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.1.4.1.3. Drug Estimates By Type
  • 6.2.1.4.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.1.4.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.1.4.2. Canada
  • 6.2.1.4.2.1. Drug Insights
  • 6.2.1.4.2.2. Drug Estimates By Route of Administration
  • 6.2.1.4.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.1.4.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.1.4.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.1.4.2.3. Drug Estimates By Type
  • 6.2.1.4.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.1.4.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.1.4.3. Mexico
  • 6.2.1.4.3.1. Drug Insights
  • 6.2.1.4.3.2. Drug Estimates By Route of Administration
  • 6.2.1.4.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.1.4.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.1.4.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.1.4.3.3. Drug Estimates By Type
  • 6.2.1.4.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.1.4.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.2. Europe
  • 6.2.2.1. UK
  • 6.2.2.1.1. Drug Insights
  • 6.2.2.1.2. Drug Estimates By Route of Administration
  • 6.2.2.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.2.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.2.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.2.1.3. Drug Estimates By Type
  • 6.2.2.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.2.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.2.2. Germany
  • 6.2.2.2.1. Drug Insights
  • 6.2.2.2.2. Drug Estimates By Route of Administration
  • 6.2.2.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.2.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.2.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.2.2.3. Drug Estimates By Type
  • 6.2.2.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.2.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.2.3. France
  • 6.2.2.3.1. Drug Insights
  • 6.2.2.3.2. Drug Estimates By Route of Administration
  • 6.2.2.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.2.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.2.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.2.3.3. Drug Estimates By Type
  • 6.2.2.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.2.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.2.4. Italy
  • 6.2.2.4.1. Drug Insights
  • 6.2.2.4.2. Drug Estimates By Route of Administration
  • 6.2.2.4.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.2.4.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.2.4.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.2.4.3. Drug Estimates By Type
  • 6.2.2.4.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.2.4.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.2.5. Spain
  • 6.2.2.5.1. Drug Insights
  • 6.2.2.5.2. Drug Estimates By Route of Administration
  • 6.2.2.5.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.2.5.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.2.5.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.2.5.3. Drug Estimates By Type
  • 6.2.2.5.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.2.5.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.2.6. Denmark
  • 6.2.2.6.1. Drug Insights
  • 6.2.2.6.2. Drug Estimates By Route of Administration
  • 6.2.2.6.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.2.6.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.2.6.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.2.6.3. Drug Estimates By Type
  • 6.2.2.6.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.2.6.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.2.7. Sweden
  • 6.2.2.7.1. Drug Insights
  • 6.2.2.7.2. Drug Estimates By Route of Administration
  • 6.2.2.7.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.2.7.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.2.7.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.2.7.3. Drug Estimates By Type
  • 6.2.2.7.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.2.7.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.2.8. Norway
  • 6.2.2.8.1. Drug Insights
  • 6.2.2.8.2. Drug Estimates By Route of Administration
  • 6.2.2.8.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.2.8.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.2.8.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.2.8.3. Drug Estimates By Type
  • 6.2.2.8.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.2.8.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.2.9. Rest of Europe
  • 6.2.2.9.1. Drug Insights
  • 6.2.2.9.2. Drug Estimates By Route of Administration
  • 6.2.2.9.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.2.9.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.2.9.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.2.9.3. Drug Estimates By Type
  • 6.2.2.9.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.2.9.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.3. Asia Pacific
  • 6.2.3.1. Japan
  • 6.2.3.1.1. Drug Insights
  • 6.2.3.1.2. Drug Estimates By Route of Administration
  • 6.2.3.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.3.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.3.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.3.1.3. Drug Estimates By Type
  • 6.2.3.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.3.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.3.2. China
  • 6.2.3.2.1. Drug Insights
  • 6.2.3.2.2. Drug Estimates By Route of Administration
  • 6.2.3.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.3.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.3.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.3.2.3. Drug Estimates By Type
  • 6.2.3.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.3.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.3.3. India
  • 6.2.3.3.1. Drug Insights
  • 6.2.3.3.2. Drug Estimates By Route of Administration
  • 6.2.3.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.3.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.3.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.3.3.3. Drug Estimates By Type
  • 6.2.3.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.3.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.3.4. South Korea
  • 6.2.3.4.1. Drug Insights
  • 6.2.3.4.2. Drug Estimates By Route of Administration
  • 6.2.3.4.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.3.4.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.3.4.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.3.4.3. Drug Estimates By Type
  • 6.2.3.4.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.3.4.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.3.5. Australia
  • 6.2.3.5.1. Drug Insights
  • 6.2.3.5.2. Drug Estimates By Route of Administration
  • 6.2.3.5.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.3.5.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.3.5.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.3.5.3. Drug Estimates By Type
  • 6.2.3.5.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.3.5.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.3.6. Thailand
  • 6.2.3.6.1. Drug Insights
  • 6.2.3.6.2. Drug Estimates By Route of Administration
  • 6.2.3.6.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.3.6.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.3.6.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.3.6.3. Drug Estimates By Type
  • 6.2.3.6.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.3.6.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.3.7. Rest of APAC
  • 6.2.3.7.1. Drug Insights
  • 6.2.3.7.2. Drug Estimates By Route of Administration
  • 6.2.3.7.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.3.7.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.3.7.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.3.7.3. Drug Estimates By Type
  • 6.2.3.7.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.3.7.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.4. Latin America
  • 6.2.4.1. Brazil
  • 6.2.4.1.1. Drug Insights
  • 6.2.4.1.2. Drug Estimates By Route of Administration
  • 6.2.4.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.4.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.4.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.4.1.3. Drug Estimates By Type
  • 6.2.4.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.4.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.4.2. Argentina
  • 6.2.4.2.1. Drug Insights
  • 6.2.4.2.2. Drug Estimates By Route of Administration
  • 6.2.4.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.4.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.4.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.4.2.3. Drug Estimates By Type
  • 6.2.4.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.4.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.4.3. Rest of Latin America
  • 6.2.4.3.1. Drug Insights
  • 6.2.4.3.2. Drug Estimates By Route of Administration
  • 6.2.4.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.4.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.4.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.4.3.3. Drug Estimates By Type
  • 6.2.4.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.4.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.5. Middle East & Africa
  • 6.2.5.1. Saudi Arabia
  • 6.2.5.1.1. Drug Insights
  • 6.2.5.1.2. Drug Estimates By Route of Administration
  • 6.2.5.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.5.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.5.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.5.1.3. Drug Estimates By Type
  • 6.2.5.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.5.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.5.2. UAE
  • 6.2.5.2.1. Drug Insights
  • 6.2.5.2.2. Drug Estimates By Route of Administration
  • 6.2.5.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.5.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.5.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.5.2.3. Drug Estimates By Type
  • 6.2.5.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.5.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.5.3. Kuwait
  • 6.2.5.3.1. Drug Insights
  • 6.2.5.3.2. Drug Estimates By Route of Administration
  • 6.2.5.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.5.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.5.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.5.3.3. Drug Estimates By Type
  • 6.2.5.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.5.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.5.4. Rest of Middle East & Africa
  • 6.2.5.4.1. Drug Insights
  • 6.2.5.4.2. Drug Estimates By Route of Administration
  • 6.2.5.4.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.5.4.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.5.4.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.5.4.3. Drug Estimates By Type
  • 6.2.5.4.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 6.2.5.4.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)

Chapter 7. Durvalumab (Imfinzi) Market Estimates & Forecast 2021-2033 (USD Mn)

  • 7.1. Drug Information
  • 7.1.1. Drug Information
  • 7.1.2. Drug Patent Analysis
  • 7.2. Drug Estimates By Region
  • 7.2.1. North America
  • 7.2.1.1. Drug Insights
  • 7.2.1.2. Drug Estimates By Route of Administration
  • 7.2.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.1.3. Drug Estimates By Type
  • 7.2.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.1.4. Drug Estimates By Country
  • 7.2.1.4.1. U.S.
  • 7.2.1.4.1.1. Drug Insight
  • 7.2.1.4.1.2. Drug Estimates By Route of Administration
  • 7.2.1.4.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.1.4.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.1.4.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.1.4.1.3. Drug Estimates By Type
  • 7.2.1.4.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.1.4.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.1.4.2. Canada
  • 7.2.1.4.2.1. Drug Insights
  • 7.2.1.4.2.2. Drug Estimates By Route of Administration
  • 7.2.1.4.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.1.4.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.1.4.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.1.4.2.3. Drug Estimates By Type
  • 7.2.1.4.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.1.4.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.1.4.3. Mexico
  • 7.2.1.4.3.1. Drug Insights
  • 7.2.1.4.3.2. Drug Estimates By Route of Administration
  • 7.2.1.4.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.1.4.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.1.4.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.1.4.3.3. Drug Estimates By Type
  • 7.2.1.4.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.1.4.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.2. Europe
  • 7.2.2.1. UK
  • 7.2.2.1.1. Drug Insights
  • 7.2.2.1.2. Drug Estimates By Route of Administration
  • 7.2.2.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.2.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.2.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.2.1.3. Drug Estimates By Type
  • 7.2.2.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.2.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.2.2. Germany
  • 7.2.2.2.1. Drug Insights
  • 7.2.2.2.2. Drug Estimates By Route of Administration
  • 7.2.2.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.2.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.2.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.2.2.3. Drug Estimates By Type
  • 7.2.2.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.2.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.2.3. France
  • 7.2.2.3.1. Drug Insights
  • 7.2.2.3.2. Drug Estimates By Route of Administration
  • 7.2.2.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.2.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.2.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.2.3.3. Drug Estimates By Type
  • 7.2.2.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.2.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.2.4. Italy
  • 7.2.2.4.1. Drug Insights
  • 7.2.2.4.2. Drug Estimates By Route of Administration
  • 7.2.2.4.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.2.4.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.2.4.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.2.4.3. Drug Estimates By Type
  • 7.2.2.4.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.2.4.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.2.5. Spain
  • 7.2.2.5.1. Drug Insights
  • 7.2.2.5.2. Drug Estimates By Route of Administration
  • 7.2.2.5.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.2.5.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.2.5.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.2.5.3. Drug Estimates By Type
  • 7.2.2.5.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.2.5.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.2.6. Denmark
  • 7.2.2.6.1. Drug Insights
  • 7.2.2.6.2. Drug Estimates By Route of Administration
  • 7.2.2.6.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.2.6.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.2.6.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.2.6.3. Drug Estimates By Type
  • 7.2.2.6.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.2.6.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.2.7. Sweden
  • 7.2.2.7.1. Drug Insights
  • 7.2.2.7.2. Drug Estimates By Route of Administration
  • 7.2.2.7.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.2.7.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.2.7.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.2.7.3. Drug Estimates By Type
  • 7.2.2.7.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.2.7.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.2.8. Norway
  • 7.2.2.8.1. Drug Insights
  • 7.2.2.8.2. Drug Estimates By Route of Administration
  • 7.2.2.8.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.2.8.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.2.8.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.2.8.3. Drug Estimates By Type
  • 7.2.2.8.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.2.8.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.2.9. Rest of Europe
  • 7.2.2.9.1. Drug Insights
  • 7.2.2.9.2. Drug Estimates By Route of Administration
  • 7.2.2.9.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.2.9.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.2.9.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.2.9.3. Drug Estimates By Type
  • 7.2.2.9.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.2.9.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.3. Asia Pacific
  • 7.2.3.1. Japan
  • 7.2.3.1.1. Drug Insights
  • 7.2.3.1.2. Drug Estimates By Route of Administration
  • 7.2.3.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.3.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.3.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.3.1.3. Drug Estimates By Type
  • 7.2.3.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.3.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.3.2. China
  • 7.2.3.2.1. Drug Insights
  • 7.2.3.2.2. Drug Estimates By Route of Administration
  • 7.2.3.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.3.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.3.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.3.2.3. Drug Estimates By Type
  • 7.2.3.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.3.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.3.3. India
  • 7.2.3.3.1. Drug Insights
  • 7.2.3.3.2. Drug Estimates By Route of Administration
  • 7.2.3.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.3.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.3.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.3.3.3. Drug Estimates By Type
  • 7.2.3.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.3.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.3.4. South Korea
  • 7.2.3.4.1. Drug Insights
  • 7.2.3.4.2. Drug Estimates By Route of Administration
  • 7.2.3.4.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.3.4.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.3.4.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.3.4.3. Drug Estimates By Type
  • 7.2.3.4.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.3.4.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.3.5. Australia
  • 7.2.3.5.1. Drug Insights
  • 7.2.3.5.2. Drug Estimates By Route of Administration
  • 7.2.3.5.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.3.5.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.3.5.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.3.5.3. Drug Estimates By Type
  • 7.2.3.5.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.3.5.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.3.6. Thailand
  • 7.2.3.6.1. Drug Insights
  • 7.2.3.6.2. Drug Estimates By Route of Administration
  • 7.2.3.6.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.3.6.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.3.6.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.3.6.3. Drug Estimates By Type
  • 7.2.3.6.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.3.6.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.3.7. Rest of APAC
  • 7.2.3.7.1. Drug Insights
  • 7.2.3.7.2. Drug Estimates By Route of Administration
  • 7.2.3.7.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.3.7.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.3.7.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.3.7.3. Drug Estimates By Type
  • 7.2.3.7.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.3.7.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.4. Latin America
  • 7.2.4.1. Brazil
  • 7.2.4.1.1. Drug Insights
  • 7.2.4.1.2. Drug Estimates By Route of Administration
  • 7.2.4.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.4.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.4.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.4.1.3. Drug Estimates By Type
  • 7.2.4.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.4.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.4.2. Argentina
  • 7.2.4.2.1. Drug Insights
  • 7.2.4.2.2. Drug Estimates By Route of Administration
  • 7.2.4.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.4.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.4.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.4.2.3. Drug Estimates By Type
  • 7.2.4.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.4.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.4.3. Rest of Latin America
  • 7.2.4.3.1. Drug Insights
  • 7.2.4.3.2. Drug Estimates By Route of Administration
  • 7.2.4.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.4.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.4.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.4.3.3. Drug Estimates By Type
  • 7.2.4.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.4.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.5. Middle East & Africa
  • 7.2.5.1. Saudi Arabia
  • 7.2.5.1.1. Drug Insights
  • 7.2.5.1.2. Drug Estimates By Route of Administration
  • 7.2.5.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.5.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.5.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.5.1.3. Drug Estimates By Type
  • 7.2.5.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.5.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.5.2. UAE
  • 7.2.5.2.1. Drug Insights
  • 7.2.5.2.2. Drug Estimates By Route of Administration
  • 7.2.5.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.5.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.5.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.5.2.3. Drug Estimates By Type
  • 7.2.5.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.5.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.5.3. Kuwait
  • 7.2.5.3.1. Drug Insights
  • 7.2.5.3.2. Drug Estimates By Route of Administration
  • 7.2.5.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.5.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.5.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.5.3.3. Drug Estimates By Type
  • 7.2.5.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.5.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.5.4. Rest of Middle East & Africa
  • 7.2.5.4.1. Drug Insights
  • 7.2.5.4.2. Drug Estimates By Route of Administration
  • 7.2.5.4.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.5.4.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.5.4.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.5.4.3. Drug Estimates By Type
  • 7.2.5.4.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 7.2.5.4.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)

Chapter 8. Trastuzumab (Kanjinti) Market Estimates & Forecast 2021-2033 (USD Mn)

  • 8.1. Drug Information
  • 8.1.1. Drug Information
  • 8.1.2. Drug Patent Analysis
  • 8.2. Drug Estimates By Region
  • 8.2.1. North America
  • 8.2.1.1. Drug Insights
  • 8.2.1.2. Drug Estimates By Route of Administration
  • 8.2.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.1.3. Drug Estimates By Type
  • 8.2.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.1.4. Drug Estimates By Country
  • 8.2.1.4.1. U.S.
  • 8.2.1.4.1.1. Drug Insight
  • 8.2.1.4.1.2. Drug Estimates By Route of Administration
  • 8.2.1.4.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.1.4.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.1.4.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.1.4.1.3. Drug Estimates By Type
  • 8.2.1.4.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.1.4.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.1.4.2. Canada
  • 8.2.1.4.2.1. Drug Insights
  • 8.2.1.4.2.2. Drug Estimates By Route of Administration
  • 8.2.1.4.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.1.4.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.1.4.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.1.4.2.3. Drug Estimates By Type
  • 8.2.1.4.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.1.4.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.1.4.3. Mexico
  • 8.2.1.4.3.1. Drug Insights
  • 8.2.1.4.3.2. Drug Estimates By Route of Administration
  • 8.2.1.4.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.1.4.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.1.4.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.1.4.3.3. Drug Estimates By Type
  • 8.2.1.4.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.1.4.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.2. Europe
  • 8.2.2.1. UK
  • 8.2.2.1.1. Drug Insights
  • 8.2.2.1.2. Drug Estimates By Route of Administration
  • 8.2.2.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.2.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.2.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.2.1.3. Drug Estimates By Type
  • 8.2.2.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.2.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.2.2. Germany
  • 8.2.2.2.1. Drug Insights
  • 8.2.2.2.2. Drug Estimates By Route of Administration
  • 8.2.2.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.2.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.2.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.2.2.3. Drug Estimates By Type
  • 8.2.2.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.2.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.2.3. France
  • 8.2.2.3.1. Drug Insights
  • 8.2.2.3.2. Drug Estimates By Route of Administration
  • 8.2.2.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.2.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.2.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.2.3.3. Drug Estimates By Type
  • 8.2.2.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.2.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.2.4. Italy
  • 8.2.2.4.1. Drug Insights
  • 8.2.2.4.2. Drug Estimates By Route of Administration
  • 8.2.2.4.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.2.4.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.2.4.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.2.4.3. Drug Estimates By Type
  • 8.2.2.4.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.2.4.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.2.5. Spain
  • 8.2.2.5.1. Drug Insights
  • 8.2.2.5.2. Drug Estimates By Route of Administration
  • 8.2.2.5.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.2.5.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.2.5.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.2.5.3. Drug Estimates By Type
  • 8.2.2.5.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.2.5.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.2.6. Denmark
  • 8.2.2.6.1. Drug Insights
  • 8.2.2.6.2. Drug Estimates By Route of Administration
  • 8.2.2.6.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.2.6.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.2.6.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.2.6.3. Drug Estimates By Type
  • 8.2.2.6.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.2.6.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.2.7. Sweden
  • 8.2.2.7.1. Drug Insights
  • 8.2.2.7.2. Drug Estimates By Route of Administration
  • 8.2.2.7.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.2.7.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.2.7.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.2.7.3. Drug Estimates By Type
  • 8.2.2.7.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.2.7.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.2.8. Norway
  • 8.2.2.8.1. Drug Insights
  • 8.2.2.8.2. Drug Estimates By Route of Administration
  • 8.2.2.8.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.2.8.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.2.8.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.2.8.3. Drug Estimates By Type
  • 8.2.2.8.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.2.8.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.2.9. Rest of Europe
  • 8.2.2.9.1. Drug Insights
  • 8.2.2.9.2. Drug Estimates By Route of Administration
  • 8.2.2.9.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.2.9.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.2.9.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.2.9.3. Drug Estimates By Type
  • 8.2.2.9.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.2.9.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.3. Asia Pacific
  • 8.2.3.1. Japan
  • 8.2.3.1.1. Drug Insights
  • 8.2.3.1.2. Drug Estimates By Route of Administration
  • 8.2.3.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.3.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.3.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.3.1.3. Drug Estimates By Type
  • 8.2.3.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.3.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.3.2. China
  • 8.2.3.2.1. Drug Insights
  • 8.2.3.2.2. Drug Estimates By Route of Administration
  • 8.2.3.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.3.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.3.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.3.2.3. Drug Estimates By Type
  • 8.2.3.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.3.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.3.3. India
  • 8.2.3.3.1. Drug Insights
  • 8.2.3.3.2. Drug Estimates By Route of Administration
  • 8.2.3.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.3.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.3.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.3.3.3. Drug Estimates By Type
  • 8.2.3.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.3.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.3.4. South Korea
  • 8.2.3.4.1. Drug Insights
  • 8.2.3.4.2. Drug Estimates By Route of Administration
  • 8.2.3.4.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.3.4.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.3.4.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.3.4.3. Drug Estimates By Type
  • 8.2.3.4.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.3.4.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.3.5. Australia
  • 8.2.3.5.1. Drug Insights
  • 8.2.3.5.2. Drug Estimates By Route of Administration
  • 8.2.3.5.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.3.5.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.3.5.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.3.5.3. Drug Estimates By Type
  • 8.2.3.5.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.3.5.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.3.6. Thailand
  • 8.2.3.6.1. Drug Insights
  • 8.2.3.6.2. Drug Estimates By Route of Administration
  • 8.2.3.6.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.3.6.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.3.6.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.3.6.3. Drug Estimates By Type
  • 8.2.3.6.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.3.6.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.3.7. Rest of APAC
  • 8.2.3.7.1. Drug Insights
  • 8.2.3.7.2. Drug Estimates By Route of Administration
  • 8.2.3.7.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.3.7.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.3.7.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.3.7.3. Drug Estimates By Type
  • 8.2.3.7.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.3.7.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.4. Latin America
  • 8.2.4.1. Brazil
  • 8.2.4.1.1. Drug Insights
  • 8.2.4.1.2. Drug Estimates By Route of Administration
  • 8.2.4.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.4.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.4.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.4.1.3. Drug Estimates By Type
  • 8.2.4.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.4.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.4.2. Argentina
  • 8.2.4.2.1. Drug Insights
  • 8.2.4.2.2. Drug Estimates By Route of Administration
  • 8.2.4.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.4.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.4.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.4.2.3. Drug Estimates By Type
  • 8.2.4.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.4.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.4.3. Rest of Latin America
  • 8.2.4.3.1. Drug Insights
  • 8.2.4.3.2. Drug Estimates By Route of Administration
  • 8.2.4.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.4.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.4.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.4.3.3. Drug Estimates By Type
  • 8.2.4.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.4.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.5. Middle East & Africa
  • 8.2.5.1. Saudi Arabia
  • 8.2.5.1.1. Drug Insights
  • 8.2.5.1.2. Drug Estimates By Route of Administration
  • 8.2.5.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.5.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.5.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.5.1.3. Drug Estimates By Type
  • 8.2.5.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.5.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.5.2. UAE
  • 8.2.5.2.1. Drug Insights
  • 8.2.5.2.2. Drug Estimates By Route of Administration
  • 8.2.5.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.5.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.5.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.5.2.3. Drug Estimates By Type
  • 8.2.5.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.5.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.5.3. Kuwait
  • 8.2.5.3.1. Drug Insights
  • 8.2.5.3.2. Drug Estimates By Route of Administration
  • 8.2.5.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.5.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.5.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.5.3.3. Drug Estimates By Type
  • 8.2.5.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.5.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.5.4. Rest of Middle East & Africa
  • 8.2.5.4.1. Drug Insights
  • 8.2.5.4.2. Drug Estimates By Route of Administration
  • 8.2.5.4.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.5.4.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.5.4.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.5.4.3. Drug Estimates By Type
  • 8.2.5.4.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 8.2.5.4.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)

Chapter 9. Trastuzumab (Ontruzant) Market Estimates & Forecast 2021-2033 (USD Mn)

  • 9.1. Drug Information
  • 9.1.1. Drug Information
  • 9.1.2. Drug Patent Analysis
  • 9.2. Drug Estimates By Region
  • 9.2.1. North America
  • 9.2.1.1. Drug Insights
  • 9.2.1.2. Drug Estimates By Route of Administration
  • 9.2.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.1.3. Drug Estimates By Type
  • 9.2.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.1.4. Drug Estimates By Country
  • 9.2.1.4.1. U.S.
  • 9.2.1.4.1.1. Drug Insight
  • 9.2.1.4.1.2. Drug Estimates By Route of Administration
  • 9.2.1.4.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.1.4.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.1.4.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.1.4.1.3. Drug Estimates By Type
  • 9.2.1.4.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.1.4.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.1.4.2. Canada
  • 9.2.1.4.2.1. Drug Insights
  • 9.2.1.4.2.2. Drug Estimates By Route of Administration
  • 9.2.1.4.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.1.4.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.1.4.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.1.4.2.3. Drug Estimates By Type
  • 9.2.1.4.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.1.4.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.1.4.3. Mexico
  • 9.2.1.4.3.1. Drug Insights
  • 9.2.1.4.3.2. Drug Estimates By Route of Administration
  • 9.2.1.4.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.1.4.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.1.4.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.1.4.3.3. Drug Estimates By Type
  • 9.2.1.4.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.1.4.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.2. Europe
  • 9.2.2.1. UK
  • 9.2.2.1.1. Drug Insights
  • 9.2.2.1.2. Drug Estimates By Route of Administration
  • 9.2.2.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.2.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.2.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.2.1.3. Drug Estimates By Type
  • 9.2.2.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.2.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.2.2. Germany
  • 9.2.2.2.1. Drug Insights
  • 9.2.2.2.2. Drug Estimates By Route of Administration
  • 9.2.2.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.2.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.2.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.2.2.3. Drug Estimates By Type
  • 9.2.2.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.2.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.2.3. France
  • 9.2.2.3.1. Drug Insights
  • 9.2.2.3.2. Drug Estimates By Route of Administration
  • 9.2.2.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.2.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.2.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.2.3.3. Drug Estimates By Type
  • 9.2.2.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.2.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.2.4. Italy
  • 9.2.2.4.1. Drug Insights
  • 9.2.2.4.2. Drug Estimates By Route of Administration
  • 9.2.2.4.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.2.4.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.2.4.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.2.4.3. Drug Estimates By Type
  • 9.2.2.4.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.2.4.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.2.5. Spain
  • 9.2.2.5.1. Drug Insights
  • 9.2.2.5.2. Drug Estimates By Route of Administration
  • 9.2.2.5.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.2.5.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.2.5.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.2.5.3. Drug Estimates By Type
  • 9.2.2.5.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.2.5.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.2.6. Denmark
  • 9.2.2.6.1. Drug Insights
  • 9.2.2.6.2. Drug Estimates By Route of Administration
  • 9.2.2.6.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.2.6.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.2.6.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.2.6.3. Drug Estimates By Type
  • 9.2.2.6.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.2.6.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.2.7. Sweden
  • 9.2.2.7.1. Drug Insights
  • 9.2.2.7.2. Drug Estimates By Route of Administration
  • 9.2.2.7.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.2.7.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.2.7.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.2.7.3. Drug Estimates By Type
  • 9.2.2.7.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.2.7.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.2.8. Norway
  • 9.2.2.8.1. Drug Insights
  • 9.2.2.8.2. Drug Estimates By Route of Administration
  • 9.2.2.8.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.2.8.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.2.8.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.2.8.3. Drug Estimates By Type
  • 9.2.2.8.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.2.8.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.2.9. Rest of Europe
  • 9.2.2.9.1. Drug Insights
  • 9.2.2.9.2. Drug Estimates By Route of Administration
  • 9.2.2.9.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.2.9.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.2.9.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.2.9.3. Drug Estimates By Type
  • 9.2.2.9.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.2.9.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.3. Asia Pacific
  • 9.2.3.1. Japan
  • 9.2.3.1.1. Drug Insights
  • 9.2.3.1.2. Drug Estimates By Route of Administration
  • 9.2.3.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.3.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.3.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.3.1.3. Drug Estimates By Type
  • 9.2.3.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.3.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.3.2. China
  • 9.2.3.2.1. Drug Insights
  • 9.2.3.2.2. Drug Estimates By Route of Administration
  • 9.2.3.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.3.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.3.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.3.2.3. Drug Estimates By Type
  • 9.2.3.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.3.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.3.3. India
  • 9.2.3.3.1. Drug Insights
  • 9.2.3.3.2. Drug Estimates By Route of Administration
  • 9.2.3.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.3.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.3.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.3.3.3. Drug Estimates By Type
  • 9.2.3.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.3.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.3.4. South Korea
  • 9.2.3.4.1. Drug Insights
  • 9.2.3.4.2. Drug Estimates By Route of Administration
  • 9.2.3.4.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.3.4.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.3.4.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.3.4.3. Drug Estimates By Type
  • 9.2.3.4.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.3.4.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.3.5. Australia
  • 9.2.3.5.1. Drug Insights
  • 9.2.3.5.2. Drug Estimates By Route of Administration
  • 9.2.3.5.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.3.5.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.3.5.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.3.5.3. Drug Estimates By Type
  • 9.2.3.5.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.3.5.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.3.6. Thailand
  • 9.2.3.6.1. Drug Insights
  • 9.2.3.6.2. Drug Estimates By Route of Administration
  • 9.2.3.6.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.3.6.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.3.6.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.3.6.3. Drug Estimates By Type
  • 9.2.3.6.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.3.6.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.3.7. Rest of APAC
  • 9.2.3.7.1. Drug Insights
  • 9.2.3.7.2. Drug Estimates By Route of Administration
  • 9.2.3.7.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.3.7.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.3.7.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.3.7.3. Drug Estimates By Type
  • 9.2.3.7.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.3.7.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.4. Latin America
  • 9.2.4.1. Brazil
  • 9.2.4.1.1. Drug Insights
  • 9.2.4.1.2. Drug Estimates By Route of Administration
  • 9.2.4.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.4.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.4.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.4.1.3. Drug Estimates By Type
  • 9.2.4.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.4.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.4.2. Argentina
  • 9.2.4.2.1. Drug Insights
  • 9.2.4.2.2. Drug Estimates By Route of Administration
  • 9.2.4.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.4.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.4.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.4.2.3. Drug Estimates By Type
  • 9.2.4.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.4.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.4.3. Rest of Latin America
  • 9.2.4.3.1. Drug Insights
  • 9.2.4.3.2. Drug Estimates By Route of Administration
  • 9.2.4.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.4.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.4.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.4.3.3. Drug Estimates By Type
  • 9.2.4.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.4.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.5. Middle East & Africa
  • 9.2.5.1. Saudi Arabia
  • 9.2.5.1.1. Drug Insights
  • 9.2.5.1.2. Drug Estimates By Route of Administration
  • 9.2.5.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.5.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.5.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.5.1.3. Drug Estimates By Type
  • 9.2.5.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.5.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.5.2. UAE
  • 9.2.5.2.1. Drug Insights
  • 9.2.5.2.2. Drug Estimates By Route of Administration
  • 9.2.5.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.5.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.5.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.5.2.3. Drug Estimates By Type
  • 9.2.5.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.5.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.5.3. Kuwait
  • 9.2.5.3.1. Drug Insights
  • 9.2.5.3.2. Drug Estimates By Route of Administration
  • 9.2.5.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.5.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.5.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.5.3.3. Drug Estimates By Type
  • 9.2.5.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.5.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.5.4. Rest of Middle East & Africa
  • 9.2.5.4.1. Drug Insights
  • 9.2.5.4.2. Drug Estimates By Route of Administration
  • 9.2.5.4.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.5.4.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.5.4.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.5.4.3. Drug Estimates By Type
  • 9.2.5.4.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 9.2.5.4.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)

Chapter 10. Sintilimab (Tyvyt) Market Estimates & Forecast 2021-2033 (USD Mn)

  • 10.1. Drug Information
  • 10.1.1. Drug Information
  • 10.1.2. Drug Patent Analysis
  • 10.2. Drug Estimates By Region
  • 10.2.1. North America
  • 10.2.1.1. Drug Insights
  • 10.2.1.2. Drug Estimates By Route of Administration
  • 10.2.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.1.3. Drug Estimates By Type
  • 10.2.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.1.4. Drug Estimates By Country
  • 10.2.1.4.1. U.S.
  • 10.2.1.4.1.1. Drug Insight
  • 10.2.1.4.1.2. Drug Estimates By Route of Administration
  • 10.2.1.4.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.1.4.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.1.4.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.1.4.1.3. Drug Estimates By Type
  • 10.2.1.4.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.1.4.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.1.4.2. Canada
  • 10.2.1.4.2.1. Drug Insights
  • 10.2.1.4.2.2. Drug Estimates By Route of Administration
  • 10.2.1.4.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.1.4.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.1.4.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.1.4.2.3. Drug Estimates By Type
  • 10.2.1.4.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.1.4.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.1.4.3. Mexico
  • 10.2.1.4.3.1. Drug Insights
  • 10.2.1.4.3.2. Drug Estimates By Route of Administration
  • 10.2.1.4.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.1.4.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.1.4.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.1.4.3.3. Drug Estimates By Type
  • 10.2.1.4.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.1.4.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.2. Europe
  • 10.2.2.1. UK
  • 10.2.2.1.1. Drug Insights
  • 10.2.2.1.2. Drug Estimates By Route of Administration
  • 10.2.2.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.2.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.2.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.2.1.3. Drug Estimates By Type
  • 10.2.2.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.2.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.2.2. Germany
  • 10.2.2.2.1. Drug Insights
  • 10.2.2.2.2. Drug Estimates By Route of Administration
  • 10.2.2.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.2.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.2.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.2.2.3. Drug Estimates By Type
  • 10.2.2.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.2.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.2.3. France
  • 10.2.2.3.1. Drug Insights
  • 10.2.2.3.2. Drug Estimates By Route of Administration
  • 10.2.2.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.2.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.2.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.2.3.3. Drug Estimates By Type
  • 10.2.2.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.2.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.2.4. Italy
  • 10.2.2.4.1. Drug Insights
  • 10.2.2.4.2. Drug Estimates By Route of Administration
  • 10.2.2.4.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.2.4.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.2.4.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.2.4.3. Drug Estimates By Type
  • 10.2.2.4.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.2.4.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.2.5. Spain
  • 10.2.2.5.1. Drug Insights
  • 10.2.2.5.2. Drug Estimates By Route of Administration
  • 10.2.2.5.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.2.5.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.2.5.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.2.5.3. Drug Estimates By Type
  • 10.2.2.5.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.2.5.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.2.6. Denmark
  • 10.2.2.6.1. Drug Insights
  • 10.2.2.6.2. Drug Estimates By Route of Administration
  • 10.2.2.6.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.2.6.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.2.6.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.2.6.3. Drug Estimates By Type
  • 10.2.2.6.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.2.6.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.2.7. Sweden
  • 10.2.2.7.1. Drug Insights
  • 10.2.2.7.2. Drug Estimates By Route of Administration
  • 10.2.2.7.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.2.7.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.2.7.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.2.7.3. Drug Estimates By Type
  • 10.2.2.7.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.2.7.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.2.8. Norway
  • 10.2.2.8.1. Drug Insights
  • 10.2.2.8.2. Drug Estimates By Route of Administration
  • 10.2.2.8.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.2.8.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.2.8.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.2.8.3. Drug Estimates By Type
  • 10.2.2.8.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.2.8.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.2.9. Rest of Europe
  • 10.2.2.9.1. Drug Insights
  • 10.2.2.9.2. Drug Estimates By Route of Administration
  • 10.2.2.9.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.2.9.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.2.9.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.2.9.3. Drug Estimates By Type
  • 10.2.2.9.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.2.9.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.3. Asia Pacific
  • 10.2.3.1. Japan
  • 10.2.3.1.1. Drug Insights
  • 10.2.3.1.2. Drug Estimates By Route of Administration
  • 10.2.3.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.3.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.3.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.3.1.3. Drug Estimates By Type
  • 10.2.3.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.3.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.3.2. China
  • 10.2.3.2.1. Drug Insights
  • 10.2.3.2.2. Drug Estimates By Route of Administration
  • 10.2.3.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.3.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.3.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.3.2.3. Drug Estimates By Type
  • 10.2.3.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.3.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.3.3. India
  • 10.2.3.3.1. Drug Insights
  • 10.2.3.3.2. Drug Estimates By Route of Administration
  • 10.2.3.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.3.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.3.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.3.3.3. Drug Estimates By Type
  • 10.2.3.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.3.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.3.4. South Korea
  • 10.2.3.4.1. Drug Insights
  • 10.2.3.4.2. Drug Estimates By Route of Administration
  • 10.2.3.4.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.3.4.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.3.4.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.3.4.3. Drug Estimates By Type
  • 10.2.3.4.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.3.4.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.3.5. Australia
  • 10.2.3.5.1. Drug Insights
  • 10.2.3.5.2. Drug Estimates By Route of Administration
  • 10.2.3.5.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.3.5.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.3.5.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.3.5.3. Drug Estimates By Type
  • 10.2.3.5.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.3.5.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.3.6. Thailand
  • 10.2.3.6.1. Drug Insights
  • 10.2.3.6.2. Drug Estimates By Route of Administration
  • 10.2.3.6.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.3.6.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.3.6.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.3.6.3. Drug Estimates By Type
  • 10.2.3.6.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.3.6.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.3.7. Rest of APAC
  • 10.2.3.7.1. Drug Insights
  • 10.2.3.7.2. Drug Estimates By Route of Administration
  • 10.2.3.7.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.3.7.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.3.7.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.3.7.3. Drug Estimates By Type
  • 10.2.3.7.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.3.7.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.4. Latin America
  • 10.2.4.1. Brazil
  • 10.2.4.1.1. Drug Insights
  • 10.2.4.1.2. Drug Estimates By Route of Administration
  • 10.2.4.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.4.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.4.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.4.1.3. Drug Estimates By Type
  • 10.2.4.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.4.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.4.2. Argentina
  • 10.2.4.2.1. Drug Insights
  • 10.2.4.2.2. Drug Estimates By Route of Administration
  • 10.2.4.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.4.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.4.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.4.2.3. Drug Estimates By Type
  • 10.2.4.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.4.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.4.3. Rest of Latin America
  • 10.2.4.3.1. Drug Insights
  • 10.2.4.3.2. Drug Estimates By Route of Administration
  • 10.2.4.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.4.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.4.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.4.3.3. Drug Estimates By Type
  • 10.2.4.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.4.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.5. Middle East & Africa
  • 10.2.5.1. Saudi Arabia
  • 10.2.5.1.1. Drug Insights
  • 10.2.5.1.2. Drug Estimates By Route of Administration
  • 10.2.5.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.5.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.5.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.5.1.3. Drug Estimates By Type
  • 10.2.5.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.5.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.5.2. UAE
  • 10.2.5.2.1. Drug Insights
  • 10.2.5.2.2. Drug Estimates By Route of Administration
  • 10.2.5.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.5.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.5.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.5.2.3. Drug Estimates By Type
  • 10.2.5.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.5.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.5.3. Kuwait
  • 10.2.5.3.1. Drug Insights
  • 10.2.5.3.2. Drug Estimates By Route of Administration
  • 10.2.5.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.5.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.5.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.5.3.3. Drug Estimates By Type
  • 10.2.5.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.5.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.5.4. Rest of Middle East & Africa
  • 10.2.5.4.1. Drug Insights
  • 10.2.5.4.2. Drug Estimates By Route of Administration
  • 10.2.5.4.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.5.4.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.5.4.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.5.4.3. Drug Estimates By Type
  • 10.2.5.4.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 10.2.5.4.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)

Chapter 11. Tislelizumab (Tevimbra) Market Estimates & Forecast 2021-2033 (USD Mn)

  • 11.1. Drug Information
  • 11.1.1. Drug Information
  • 11.1.2. Drug Patent Analysis
  • 11.2. Drug Estimates By Region
  • 11.2.1. North America
  • 11.2.1.1. Drug Insights
  • 11.2.1.2. Drug Estimates By Route of Administration
  • 11.2.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.1.3. Drug Estimates By Type
  • 11.2.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.1.4. Drug Estimates By Country
  • 11.2.1.4.1. U.S.
  • 11.2.1.4.1.1. Drug Insight
  • 11.2.1.4.1.2. Drug Estimates By Route of Administration
  • 11.2.1.4.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.1.4.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.1.4.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.1.4.1.3. Drug Estimates By Type
  • 11.2.1.4.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.1.4.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.1.4.2. Canada
  • 11.2.1.4.2.1. Drug Insights
  • 11.2.1.4.2.2. Drug Estimates By Route of Administration
  • 11.2.1.4.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.1.4.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.1.4.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.1.4.2.3. Drug Estimates By Type
  • 11.2.1.4.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.1.4.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.1.4.3. Mexico
  • 11.2.1.4.3.1. Drug Insights
  • 11.2.1.4.3.2. Drug Estimates By Route of Administration
  • 11.2.1.4.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.1.4.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.1.4.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.1.4.3.3. Drug Estimates By Type
  • 11.2.1.4.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.1.4.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.2. Europe
  • 11.2.2.1. UK
  • 11.2.2.1.1. Drug Insights
  • 11.2.2.1.2. Drug Estimates By Route of Administration
  • 11.2.2.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.2.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.2.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.2.1.3. Drug Estimates By Type
  • 11.2.2.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.2.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.2.2. Germany
  • 11.2.2.2.1. Drug Insights
  • 11.2.2.2.2. Drug Estimates By Route of Administration
  • 11.2.2.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.2.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.2.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.2.2.3. Drug Estimates By Type
  • 11.2.2.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.2.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.2.3. France
  • 11.2.2.3.1. Drug Insights
  • 11.2.2.3.2. Drug Estimates By Route of Administration
  • 11.2.2.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.2.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.2.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.2.3.3. Drug Estimates By Type
  • 11.2.2.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.2.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.2.4. Italy
  • 11.2.2.4.1. Drug Insights
  • 11.2.2.4.2. Drug Estimates By Route of Administration
  • 11.2.2.4.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.2.4.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.2.4.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.2.4.3. Drug Estimates By Type
  • 11.2.2.4.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.2.4.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.2.5. Spain
  • 11.2.2.5.1. Drug Insights
  • 11.2.2.5.2. Drug Estimates By Route of Administration
  • 11.2.2.5.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.2.5.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.2.5.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.2.5.3. Drug Estimates By Type
  • 11.2.2.5.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.2.5.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.2.6. Denmark
  • 11.2.2.6.1. Drug Insights
  • 11.2.2.6.2. Drug Estimates By Route of Administration
  • 11.2.2.6.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.2.6.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.2.6.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.2.6.3. Drug Estimates By Type
  • 11.2.2.6.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.2.6.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.2.7. Sweden
  • 11.2.2.7.1. Drug Insights
  • 11.2.2.7.2. Drug Estimates By Route of Administration
  • 11.2.2.7.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.2.7.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.2.7.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.2.7.3. Drug Estimates By Type
  • 11.2.2.7.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.2.7.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.2.8. Norway
  • 11.2.2.8.1. Drug Insights
  • 11.2.2.8.2. Drug Estimates By Route of Administration
  • 11.2.2.8.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.2.8.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.2.8.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.2.8.3. Drug Estimates By Type
  • 11.2.2.8.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.2.8.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.2.9. Rest of Europe
  • 11.2.2.9.1. Drug Insights
  • 11.2.2.9.2. Drug Estimates By Route of Administration
  • 11.2.2.9.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.2.9.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.2.9.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.2.9.3. Drug Estimates By Type
  • 11.2.2.9.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.2.9.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.3. Asia Pacific
  • 11.2.3.1. Japan
  • 11.2.3.1.1. Drug Insights
  • 11.2.3.1.2. Drug Estimates By Route of Administration
  • 11.2.3.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.3.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.3.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.3.1.3. Drug Estimates By Type
  • 11.2.3.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.3.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.3.2. China
  • 11.2.3.2.1. Drug Insights
  • 11.2.3.2.2. Drug Estimates By Route of Administration
  • 11.2.3.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.3.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.3.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.3.2.3. Drug Estimates By Type
  • 11.2.3.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.3.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.3.3. India
  • 11.2.3.3.1. Drug Insights
  • 11.2.3.3.2. Drug Estimates By Route of Administration
  • 11.2.3.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.3.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.3.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.3.3.3. Drug Estimates By Type
  • 11.2.3.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.3.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.3.4. South Korea
  • 11.2.3.4.1. Drug Insights
  • 11.2.3.4.2. Drug Estimates By Route of Administration
  • 11.2.3.4.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.3.4.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.3.4.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.3.4.3. Drug Estimates By Type
  • 11.2.3.4.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.3.4.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.3.5. Australia
  • 11.2.3.5.1. Drug Insights
  • 11.2.3.5.2. Drug Estimates By Route of Administration
  • 11.2.3.5.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.3.5.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.3.5.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.3.5.3. Drug Estimates By Type
  • 11.2.3.5.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.3.5.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.3.6. Thailand
  • 11.2.3.6.1. Drug Insights
  • 11.2.3.6.2. Drug Estimates By Route of Administration
  • 11.2.3.6.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.3.6.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.3.6.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.3.6.3. Drug Estimates By Type
  • 11.2.3.6.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.3.6.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.3.7. Rest of APAC
  • 11.2.3.7.1. Drug Insights
  • 11.2.3.7.2. Drug Estimates By Route of Administration
  • 11.2.3.7.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.3.7.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.3.7.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.3.7.3. Drug Estimates By Type
  • 11.2.3.7.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.3.7.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.4. Latin America
  • 11.2.4.1. Brazil
  • 11.2.4.1.1. Drug Insights
  • 11.2.4.1.2. Drug Estimates By Route of Administration
  • 11.2.4.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.4.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.4.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.4.1.3. Drug Estimates By Type
  • 11.2.4.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.4.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.4.2. Argentina
  • 11.2.4.2.1. Drug Insights
  • 11.2.4.2.2. Drug Estimates By Route of Administration
  • 11.2.4.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.4.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.4.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.4.2.3. Drug Estimates By Type
  • 11.2.4.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.4.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.4.3. Rest of Latin America
  • 11.2.4.3.1. Drug Insights
  • 11.2.4.3.2. Drug Estimates By Route of Administration
  • 11.2.4.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.4.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.4.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.4.3.3. Drug Estimates By Type
  • 11.2.4.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.4.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.5. Middle East & Africa
  • 11.2.5.1. Saudi Arabia
  • 11.2.5.1.1. Drug Insights
  • 11.2.5.1.2. Drug Estimates By Route of Administration
  • 11.2.5.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.5.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.5.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.5.1.3. Drug Estimates By Type
  • 11.2.5.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.5.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.5.2. UAE
  • 11.2.5.2.1. Drug Insights
  • 11.2.5.2.2. Drug Estimates By Route of Administration
  • 11.2.5.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.5.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.5.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.5.2.3. Drug Estimates By Type
  • 11.2.5.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.5.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.5.3. Kuwait
  • 11.2.5.3.1. Drug Insights
  • 11.2.5.3.2. Drug Estimates By Route of Administration
  • 11.2.5.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.5.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.5.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.5.3.3. Drug Estimates By Type
  • 11.2.5.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.5.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.5.4. Rest of Middle East & Africa
  • 11.2.5.4.1. Drug Insights
  • 11.2.5.4.2. Drug Estimates By Route of Administration
  • 11.2.5.4.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.5.4.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.5.4.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.5.4.3. Drug Estimates By Type
  • 11.2.5.4.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 11.2.5.4.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)

Chapter 12. Trastuzumab (Herceptin) Market Estimates & Forecast 2021-2033 (USD Mn)

  • 12.1. Drug Information
  • 12.1.1. Drug Information
  • 12.1.2. Drug Patent Analysis
  • 12.2. Drug Estimates By Region
  • 12.2.1. North America
  • 12.2.1.1. Drug Insights
  • 12.2.1.2. Drug Estimates By Route of Administration
  • 12.2.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.1.3. Drug Estimates By Type
  • 12.2.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.1.4. Drug Estimates By Country
  • 12.2.1.4.1. U.S.
  • 12.2.1.4.1.1. Drug Insight
  • 12.2.1.4.1.2. Drug Estimates By Route of Administration
  • 12.2.1.4.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.1.4.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.1.4.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.1.4.1.3. Drug Estimates By Type
  • 12.2.1.4.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.1.4.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.1.4.2. Canada
  • 12.2.1.4.2.1. Drug Insights
  • 12.2.1.4.2.2. Drug Estimates By Route of Administration
  • 12.2.1.4.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.1.4.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.1.4.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.1.4.2.3. Drug Estimates By Type
  • 12.2.1.4.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.1.4.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.1.4.3. Mexico
  • 12.2.1.4.3.1. Drug Insights
  • 12.2.1.4.3.2. Drug Estimates By Route of Administration
  • 12.2.1.4.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.1.4.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.1.4.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.1.4.3.3. Drug Estimates By Type
  • 12.2.1.4.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.1.4.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.2. Europe
  • 12.2.2.1. UK
  • 12.2.2.1.1. Drug Insights
  • 12.2.2.1.2. Drug Estimates By Route of Administration
  • 12.2.2.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.2.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.2.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.2.1.3. Drug Estimates By Type
  • 12.2.2.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.2.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.2.2. Germany
  • 12.2.2.2.1. Drug Insights
  • 12.2.2.2.2. Drug Estimates By Route of Administration
  • 12.2.2.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.2.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.2.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.2.2.3. Drug Estimates By Type
  • 12.2.2.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.2.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.2.3. France
  • 12.2.2.3.1. Drug Insights
  • 12.2.2.3.2. Drug Estimates By Route of Administration
  • 12.2.2.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.2.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.2.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.2.3.3. Drug Estimates By Type
  • 12.2.2.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.2.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.2.4. Italy
  • 12.2.2.4.1. Drug Insights
  • 12.2.2.4.2. Drug Estimates By Route of Administration
  • 12.2.2.4.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.2.4.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.2.4.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.2.4.3. Drug Estimates By Type
  • 12.2.2.4.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.2.4.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.2.5. Spain
  • 12.2.2.5.1. Drug Insights
  • 12.2.2.5.2. Drug Estimates By Route of Administration
  • 12.2.2.5.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.2.5.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.2.5.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.2.5.3. Drug Estimates By Type
  • 12.2.2.5.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.2.5.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.2.6. Denmark
  • 12.2.2.6.1. Drug Insights
  • 12.2.2.6.2. Drug Estimates By Route of Administration
  • 12.2.2.6.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.2.6.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.2.6.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.2.6.3. Drug Estimates By Type
  • 12.2.2.6.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.2.6.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.2.7. Sweden
  • 12.2.2.7.1. Drug Insights
  • 12.2.2.7.2. Drug Estimates By Route of Administration
  • 12.2.2.7.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.2.7.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.2.7.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.2.7.3. Drug Estimates By Type
  • 12.2.2.7.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.2.7.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.2.8. Norway
  • 12.2.2.8.1. Drug Insights
  • 12.2.2.8.2. Drug Estimates By Route of Administration
  • 12.2.2.8.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.2.8.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.2.8.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.2.8.3. Drug Estimates By Type
  • 12.2.2.8.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.2.8.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.2.9. Rest of Europe
  • 12.2.2.9.1. Drug Insights
  • 12.2.2.9.2. Drug Estimates By Route of Administration
  • 12.2.2.9.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.2.9.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.2.9.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.2.9.3. Drug Estimates By Type
  • 12.2.2.9.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.2.9.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.3. Asia Pacific
  • 12.2.3.1. Japan
  • 12.2.3.1.1. Drug Insights
  • 12.2.3.1.2. Drug Estimates By Route of Administration
  • 12.2.3.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.3.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.3.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.3.1.3. Drug Estimates By Type
  • 12.2.3.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.3.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.3.2. China
  • 12.2.3.2.1. Drug Insights
  • 12.2.3.2.2. Drug Estimates By Route of Administration
  • 12.2.3.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.3.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.3.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.3.2.3. Drug Estimates By Type
  • 12.2.3.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.3.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.3.3. India
  • 12.2.3.3.1. Drug Insights
  • 12.2.3.3.2. Drug Estimates By Route of Administration
  • 12.2.3.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.3.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.3.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.3.3.3. Drug Estimates By Type
  • 12.2.3.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.3.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.3.4. South Korea
  • 12.2.3.4.1. Drug Insights
  • 12.2.3.4.2. Drug Estimates By Route of Administration
  • 12.2.3.4.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.3.4.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.3.4.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.3.4.3. Drug Estimates By Type
  • 12.2.3.4.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.3.4.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.3.5. Australia
  • 12.2.3.5.1. Drug Insights
  • 12.2.3.5.2. Drug Estimates By Route of Administration
  • 12.2.3.5.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.3.5.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.3.5.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.3.5.3. Drug Estimates By Type
  • 12.2.3.5.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.3.5.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.3.6. Thailand
  • 12.2.3.6.1. Drug Insights
  • 12.2.3.6.2. Drug Estimates By Route of Administration
  • 12.2.3.6.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.3.6.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.3.6.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.3.6.3. Drug Estimates By Type
  • 12.2.3.6.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.3.6.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.3.7. Rest of APAC
  • 12.2.3.7.1. Drug Insights
  • 12.2.3.7.2. Drug Estimates By Route of Administration
  • 12.2.3.7.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.3.7.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.3.7.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.3.7.3. Drug Estimates By Type
  • 12.2.3.7.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.3.7.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.4. Latin America
  • 12.2.4.1. Brazil
  • 12.2.4.1.1. Drug Insights
  • 12.2.4.1.2. Drug Estimates By Route of Administration
  • 12.2.4.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.4.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.4.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.4.1.3. Drug Estimates By Type
  • 12.2.4.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.4.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.4.2. Argentina
  • 12.2.4.2.1. Drug Insights
  • 12.2.4.2.2. Drug Estimates By Route of Administration
  • 12.2.4.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.4.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.4.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.4.2.3. Drug Estimates By Type
  • 12.2.4.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.4.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.4.3. Rest of Latin America
  • 12.2.4.3.1. Drug Insights
  • 12.2.4.3.2. Drug Estimates By Route of Administration
  • 12.2.4.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.4.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.4.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.4.3.3. Drug Estimates By Type
  • 12.2.4.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.4.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.5. Middle East & Africa
  • 12.2.5.1. Saudi Arabia
  • 12.2.5.1.1. Drug Insights
  • 12.2.5.1.2. Drug Estimates By Route of Administration
  • 12.2.5.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.5.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.5.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.5.1.3. Drug Estimates By Type
  • 12.2.5.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.5.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.5.2. UAE
  • 12.2.5.2.1. Drug Insights
  • 12.2.5.2.2. Drug Estimates By Route of Administration
  • 12.2.5.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.5.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.5.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.5.2.3. Drug Estimates By Type
  • 12.2.5.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.5.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.5.3. Kuwait
  • 12.2.5.3.1. Drug Insights
  • 12.2.5.3.2. Drug Estimates By Route of Administration
  • 12.2.5.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.5.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.5.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.5.3.3. Drug Estimates By Type
  • 12.2.5.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.5.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.5.4. Rest of Middle East & Africa
  • 12.2.5.4.1. Drug Insights
  • 12.2.5.4.2. Drug Estimates By Route of Administration
  • 12.2.5.4.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.5.4.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.5.4.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.5.4.3. Drug Estimates By Type
  • 12.2.5.4.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 12.2.5.4.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)

Chapter 13. Trastuzumab (Trazimera) Market Estimates & Forecast 2021-2033 (USD Mn)

  • 13.1. Drug Information
  • 13.1.1. Drug Information
  • 13.1.2. Drug Patent Analysis
  • 13.2. Drug Estimates By Region
  • 13.2.1. North America
  • 13.2.1.1. Drug Insights
  • 13.2.1.2. Drug Estimates By Route of Administration
  • 13.2.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.1.3. Drug Estimates By Type
  • 13.2.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.1.4. Drug Estimates By Country
  • 13.2.1.4.1. U.S.
  • 13.2.1.4.1.1. Drug Insight
  • 13.2.1.4.1.2. Drug Estimates By Route of Administration
  • 13.2.1.4.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.1.4.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.1.4.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.1.4.1.3. Drug Estimates By Type
  • 13.2.1.4.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.1.4.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.1.4.2. Canada
  • 13.2.1.4.2.1. Drug Insights
  • 13.2.1.4.2.2. Drug Estimates By Route of Administration
  • 13.2.1.4.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.1.4.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.1.4.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.1.4.2.3. Drug Estimates By Type
  • 13.2.1.4.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.1.4.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.1.4.3. Mexico
  • 13.2.1.4.3.1. Drug Insights
  • 13.2.1.4.3.2. Drug Estimates By Route of Administration
  • 13.2.1.4.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.1.4.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.1.4.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.1.4.3.3. Drug Estimates By Type
  • 13.2.1.4.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.1.4.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.2. Europe
  • 13.2.2.1. UK
  • 13.2.2.1.1. Drug Insights
  • 13.2.2.1.2. Drug Estimates By Route of Administration
  • 13.2.2.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.2.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.2.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.2.1.3. Drug Estimates By Type
  • 13.2.2.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.2.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.2.2. Germany
  • 13.2.2.2.1. Drug Insights
  • 13.2.2.2.2. Drug Estimates By Route of Administration
  • 13.2.2.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.2.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.2.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.2.2.3. Drug Estimates By Type
  • 13.2.2.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.2.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.2.3. France
  • 13.2.2.3.1. Drug Insights
  • 13.2.2.3.2. Drug Estimates By Route of Administration
  • 13.2.2.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.2.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.2.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.2.3.3. Drug Estimates By Type
  • 13.2.2.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.2.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.2.4. Italy
  • 13.2.2.4.1. Drug Insights
  • 13.2.2.4.2. Drug Estimates By Route of Administration
  • 13.2.2.4.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.2.4.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.2.4.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.2.4.3. Drug Estimates By Type
  • 13.2.2.4.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.2.4.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.2.5. Spain
  • 13.2.2.5.1. Drug Insights
  • 13.2.2.5.2. Drug Estimates By Route of Administration
  • 13.2.2.5.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.2.5.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.2.5.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.2.5.3. Drug Estimates By Type
  • 13.2.2.5.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.2.5.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.2.6. Denmark
  • 13.2.2.6.1. Drug Insights
  • 13.2.2.6.2. Drug Estimates By Route of Administration
  • 13.2.2.6.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.2.6.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.2.6.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.2.6.3. Drug Estimates By Type
  • 13.2.2.6.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.2.6.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.2.7. Sweden
  • 13.2.2.7.1. Drug Insights
  • 13.2.2.7.2. Drug Estimates By Route of Administration
  • 13.2.2.7.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.2.7.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.2.7.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.2.7.3. Drug Estimates By Type
  • 13.2.2.7.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.2.7.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.2.8. Norway
  • 13.2.2.8.1. Drug Insights
  • 13.2.2.8.2. Drug Estimates By Route of Administration
  • 13.2.2.8.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.2.8.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.2.8.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.2.8.3. Drug Estimates By Type
  • 13.2.2.8.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.2.8.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.2.9. Rest of Europe
  • 13.2.2.9.1. Drug Insights
  • 13.2.2.9.2. Drug Estimates By Route of Administration
  • 13.2.2.9.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.2.9.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.2.9.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.2.9.3. Drug Estimates By Type
  • 13.2.2.9.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.2.9.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.3. Asia Pacific
  • 13.2.3.1. Japan
  • 13.2.3.1.1. Drug Insights
  • 13.2.3.1.2. Drug Estimates By Route of Administration
  • 13.2.3.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.3.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.3.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.3.1.3. Drug Estimates By Type
  • 13.2.3.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.3.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.3.2. China
  • 13.2.3.2.1. Drug Insights
  • 13.2.3.2.2. Drug Estimates By Route of Administration
  • 13.2.3.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.3.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.3.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.3.2.3. Drug Estimates By Type
  • 13.2.3.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.3.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.3.3. India
  • 13.2.3.3.1. Drug Insights
  • 13.2.3.3.2. Drug Estimates By Route of Administration
  • 13.2.3.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.3.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.3.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.3.3.3. Drug Estimates By Type
  • 13.2.3.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.3.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.3.4. South Korea
  • 13.2.3.4.1. Drug Insights
  • 13.2.3.4.2. Drug Estimates By Route of Administration
  • 13.2.3.4.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.3.4.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.3.4.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.3.4.3. Drug Estimates By Type
  • 13.2.3.4.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.3.4.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.3.5. Australia
  • 13.2.3.5.1. Drug Insights
  • 13.2.3.5.2. Drug Estimates By Route of Administration
  • 13.2.3.5.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.3.5.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.3.5.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.3.5.3. Drug Estimates By Type
  • 13.2.3.5.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.3.5.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.3.6. Thailand
  • 13.2.3.6.1. Drug Insights
  • 13.2.3.6.2. Drug Estimates By Route of Administration
  • 13.2.3.6.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.3.6.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.3.6.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.3.6.3. Drug Estimates By Type
  • 13.2.3.6.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.3.6.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.3.7. Rest of APAC
  • 13.2.3.7.1. Drug Insights
  • 13.2.3.7.2. Drug Estimates By Route of Administration
  • 13.2.3.7.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.3.7.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.3.7.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.3.7.3. Drug Estimates By Type
  • 13.2.3.7.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.3.7.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.4. Latin America
  • 13.2.4.1. Brazil
  • 13.2.4.1.1. Drug Insights
  • 13.2.4.1.2. Drug Estimates By Route of Administration
  • 13.2.4.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.4.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.4.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.4.1.3. Drug Estimates By Type
  • 13.2.4.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.4.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.4.2. Argentina
  • 13.2.4.2.1. Drug Insights
  • 13.2.4.2.2. Drug Estimates By Route of Administration
  • 13.2.4.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.4.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.4.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.4.2.3. Drug Estimates By Type
  • 13.2.4.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.4.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.4.3. Rest of Latin America
  • 13.2.4.3.1. Drug Insights
  • 13.2.4.3.2. Drug Estimates By Route of Administration
  • 13.2.4.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.4.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.4.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.4.3.3. Drug Estimates By Type
  • 13.2.4.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.4.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.5. Middle East & Africa
  • 13.2.5.1. Saudi Arabia
  • 13.2.5.1.1. Drug Insights
  • 13.2.5.1.2. Drug Estimates By Route of Administration
  • 13.2.5.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.5.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.5.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.5.1.3. Drug Estimates By Type
  • 13.2.5.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.5.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.5.2. UAE
  • 13.2.5.2.1. Drug Insights
  • 13.2.5.2.2. Drug Estimates By Route of Administration
  • 13.2.5.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.5.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.5.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.5.2.3. Drug Estimates By Type
  • 13.2.5.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.5.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.5.3. Kuwait
  • 13.2.5.3.1. Drug Insights
  • 13.2.5.3.2. Drug Estimates By Route of Administration
  • 13.2.5.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.5.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.5.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.5.3.3. Drug Estimates By Type
  • 13.2.5.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.5.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.5.4. Rest of Middle East & Africa
  • 13.2.5.4.1. Drug Insights
  • 13.2.5.4.2. Drug Estimates By Route of Administration
  • 13.2.5.4.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.5.4.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.5.4.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.5.4.3. Drug Estimates By Type
  • 13.2.5.4.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 13.2.5.4.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)

Chapter 14. Trifluridine and Tipiracil (Lonsurf) Market Estimates & Forecast 2021-2033 (USD Mn)

  • 14.1. Drug Information
  • 14.1.1. Drug Information
  • 14.1.2. Drug Patent Analysis
  • 14.2. Drug Estimates By Region
  • 14.2.1. North America
  • 14.2.1.1. Drug Insights
  • 14.2.1.2. Drug Estimates By Route of Administration
  • 14.2.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.1.3. Drug Estimates By Type
  • 14.2.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.1.4. Drug Estimates By Country
  • 14.2.1.4.1. U.S.
  • 14.2.1.4.1.1. Drug Insight
  • 14.2.1.4.1.2. Drug Estimates By Route of Administration
  • 14.2.1.4.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.1.4.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.1.4.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.1.4.1.3. Drug Estimates By Type
  • 14.2.1.4.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.1.4.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.1.4.2. Canada
  • 14.2.1.4.2.1. Drug Insights
  • 14.2.1.4.2.2. Drug Estimates By Route of Administration
  • 14.2.1.4.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.1.4.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.1.4.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.1.4.2.3. Drug Estimates By Type
  • 14.2.1.4.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.1.4.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.1.4.3. Mexico
  • 14.2.1.4.3.1. Drug Insights
  • 14.2.1.4.3.2. Drug Estimates By Route of Administration
  • 14.2.1.4.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.1.4.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.1.4.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.1.4.3.3. Drug Estimates By Type
  • 14.2.1.4.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.1.4.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.2. Europe
  • 14.2.2.1. UK
  • 14.2.2.1.1. Drug Insights
  • 14.2.2.1.2. Drug Estimates By Route of Administration
  • 14.2.2.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.2.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.2.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.2.1.3. Drug Estimates By Type
  • 14.2.2.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.2.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.2.2. Germany
  • 14.2.2.2.1. Drug Insights
  • 14.2.2.2.2. Drug Estimates By Route of Administration
  • 14.2.2.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.2.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.2.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.2.2.3. Drug Estimates By Type
  • 14.2.2.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.2.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.2.3. France
  • 14.2.2.3.1. Drug Insights
  • 14.2.2.3.2. Drug Estimates By Route of Administration
  • 14.2.2.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.2.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.2.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.2.3.3. Drug Estimates By Type
  • 14.2.2.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.2.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.2.4. Italy
  • 14.2.2.4.1. Drug Insights
  • 14.2.2.4.2. Drug Estimates By Route of Administration
  • 14.2.2.4.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.2.4.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.2.4.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.2.4.3. Drug Estimates By Type
  • 14.2.2.4.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.2.4.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.2.5. Spain
  • 14.2.2.5.1. Drug Insights
  • 14.2.2.5.2. Drug Estimates By Route of Administration
  • 14.2.2.5.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.2.5.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.2.5.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.2.5.3. Drug Estimates By Type
  • 14.2.2.5.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.2.5.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.2.6. Denmark
  • 14.2.2.6.1. Drug Insights
  • 14.2.2.6.2. Drug Estimates By Route of Administration
  • 14.2.2.6.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.2.6.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.2.6.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.2.6.3. Drug Estimates By Type
  • 14.2.2.6.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.2.6.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.2.7. Sweden
  • 14.2.2.7.1. Drug Insights
  • 14.2.2.7.2. Drug Estimates By Route of Administration
  • 14.2.2.7.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.2.7.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.2.7.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.2.7.3. Drug Estimates By Type
  • 14.2.2.7.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.2.7.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.2.8. Norway
  • 14.2.2.8.1. Drug Insights
  • 14.2.2.8.2. Drug Estimates By Route of Administration
  • 14.2.2.8.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.2.8.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.2.8.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.2.8.3. Drug Estimates By Type
  • 14.2.2.8.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.2.8.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.2.9. Rest of Europe
  • 14.2.2.9.1. Drug Insights
  • 14.2.2.9.2. Drug Estimates By Route of Administration
  • 14.2.2.9.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.2.9.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.2.9.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.2.9.3. Drug Estimates By Type
  • 14.2.2.9.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.2.9.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.3. Asia Pacific
  • 14.2.3.1. Japan
  • 14.2.3.1.1. Drug Insights
  • 14.2.3.1.2. Drug Estimates By Route of Administration
  • 14.2.3.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.3.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.3.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.3.1.3. Drug Estimates By Type
  • 14.2.3.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.3.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.3.2. China
  • 14.2.3.2.1. Drug Insights
  • 14.2.3.2.2. Drug Estimates By Route of Administration
  • 14.2.3.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.3.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.3.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.3.2.3. Drug Estimates By Type
  • 14.2.3.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.3.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.3.3. India
  • 14.2.3.3.1. Drug Insights
  • 14.2.3.3.2. Drug Estimates By Route of Administration
  • 14.2.3.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.3.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.3.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.3.3.3. Drug Estimates By Type
  • 14.2.3.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.3.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.3.4. South Korea
  • 14.2.3.4.1. Drug Insights
  • 14.2.3.4.2. Drug Estimates By Route of Administration
  • 14.2.3.4.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.3.4.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.3.4.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.3.4.3. Drug Estimates By Type
  • 14.2.3.4.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.3.4.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.3.5. Australia
  • 14.2.3.5.1. Drug Insights
  • 14.2.3.5.2. Drug Estimates By Route of Administration
  • 14.2.3.5.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.3.5.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.3.5.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.3.5.3. Drug Estimates By Type
  • 14.2.3.5.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.3.5.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.3.6. Thailand
  • 14.2.3.6.1. Drug Insights
  • 14.2.3.6.2. Drug Estimates By Route of Administration
  • 14.2.3.6.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.3.6.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.3.6.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.3.6.3. Drug Estimates By Type
  • 14.2.3.6.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.3.6.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.3.7. Rest of APAC
  • 14.2.3.7.1. Drug Insights
  • 14.2.3.7.2. Drug Estimates By Route of Administration
  • 14.2.3.7.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.3.7.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.3.7.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.3.7.3. Drug Estimates By Type
  • 14.2.3.7.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.3.7.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.4. Latin America
  • 14.2.4.1. Brazil
  • 14.2.4.1.1. Drug Insights
  • 14.2.4.1.2. Drug Estimates By Route of Administration
  • 14.2.4.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.4.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.4.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.4.1.3. Drug Estimates By Type
  • 14.2.4.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.4.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.4.2. Argentina
  • 14.2.4.2.1. Drug Insights
  • 14.2.4.2.2. Drug Estimates By Route of Administration
  • 14.2.4.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.4.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.4.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.4.2.3. Drug Estimates By Type
  • 14.2.4.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.4.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.4.3. Rest of Latin America
  • 14.2.4.3.1. Drug Insights
  • 14.2.4.3.2. Drug Estimates By Route of Administration
  • 14.2.4.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.4.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.4.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.4.3.3. Drug Estimates By Type
  • 14.2.4.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.4.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.5. Middle East & Africa
  • 14.2.5.1. Saudi Arabia
  • 14.2.5.1.1. Drug Insights
  • 14.2.5.1.2. Drug Estimates By Route of Administration
  • 14.2.5.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.5.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.5.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.5.1.3. Drug Estimates By Type
  • 14.2.5.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.5.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.5.2. UAE
  • 14.2.5.2.1. Drug Insights
  • 14.2.5.2.2. Drug Estimates By Route of Administration
  • 14.2.5.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.5.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.5.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.5.2.3. Drug Estimates By Type
  • 14.2.5.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.5.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.5.3. Kuwait
  • 14.2.5.3.1. Drug Insights
  • 14.2.5.3.2. Drug Estimates By Route of Administration
  • 14.2.5.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.5.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.5.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.5.3.3. Drug Estimates By Type
  • 14.2.5.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.5.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.5.4. Rest of Middle East & Africa
  • 14.2.5.4.1. Drug Insights
  • 14.2.5.4.2. Drug Estimates By Route of Administration
  • 14.2.5.4.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.5.4.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.5.4.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.5.4.3. Drug Estimates By Type
  • 14.2.5.4.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 14.2.5.4.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)

Chapter 15. Zolbetuximab-clzb (Vyloy) Market Estimates & Forecast 2021-2033 (USD Mn)

  • 15.1. Drug Information
  • 15.1.1. Drug Information
  • 15.1.2. Drug Patent Analysis
  • 15.2. Drug Estimates By Region
  • 15.2.1. North America
  • 15.2.1.1. Drug Insights
  • 15.2.1.2. Drug Estimates By Route of Administration
  • 15.2.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.1.3. Drug Estimates By Type
  • 15.2.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.1.4. Drug Estimates By Country
  • 15.2.1.4.1. U.S.
  • 15.2.1.4.1.1. Drug Insight
  • 15.2.1.4.1.2. Drug Estimates By Route of Administration
  • 15.2.1.4.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.1.4.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.1.4.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.1.4.1.3. Drug Estimates By Type
  • 15.2.1.4.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.1.4.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.1.4.2. Canada
  • 15.2.1.4.2.1. Drug Insights
  • 15.2.1.4.2.2. Drug Estimates By Route of Administration
  • 15.2.1.4.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.1.4.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.1.4.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.1.4.2.3. Drug Estimates By Type
  • 15.2.1.4.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.1.4.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.1.4.3. Mexico
  • 15.2.1.4.3.1. Drug Insights
  • 15.2.1.4.3.2. Drug Estimates By Route of Administration
  • 15.2.1.4.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.1.4.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.1.4.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.1.4.3.3. Drug Estimates By Type
  • 15.2.1.4.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.1.4.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.2. Europe
  • 15.2.2.1. UK
  • 15.2.2.1.1. Drug Insights
  • 15.2.2.1.2. Drug Estimates By Route of Administration
  • 15.2.2.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.2.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.2.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.2.1.3. Drug Estimates By Type
  • 15.2.2.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.2.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.2.2. Germany
  • 15.2.2.2.1. Drug Insights
  • 15.2.2.2.2. Drug Estimates By Route of Administration
  • 15.2.2.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.2.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.2.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.2.2.3. Drug Estimates By Type
  • 15.2.2.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.2.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.2.3. France
  • 15.2.2.3.1. Drug Insights
  • 15.2.2.3.2. Drug Estimates By Route of Administration
  • 15.2.2.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.2.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.2.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.2.3.3. Drug Estimates By Type
  • 15.2.2.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.2.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.2.4. Italy
  • 15.2.2.4.1. Drug Insights
  • 15.2.2.4.2. Drug Estimates By Route of Administration
  • 15.2.2.4.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.2.4.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.2.4.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.2.4.3. Drug Estimates By Type
  • 15.2.2.4.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.2.4.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.2.5. Spain
  • 15.2.2.5.1. Drug Insights
  • 15.2.2.5.2. Drug Estimates By Route of Administration
  • 15.2.2.5.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.2.5.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.2.5.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.2.5.3. Drug Estimates By Type
  • 15.2.2.5.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.2.5.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.2.6. Denmark
  • 15.2.2.6.1. Drug Insights
  • 15.2.2.6.2. Drug Estimates By Route of Administration
  • 15.2.2.6.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.2.6.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.2.6.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.2.6.3. Drug Estimates By Type
  • 15.2.2.6.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.2.6.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.2.7. Sweden
  • 15.2.2.7.1. Drug Insights
  • 15.2.2.7.2. Drug Estimates By Route of Administration
  • 15.2.2.7.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.2.7.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.2.7.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.2.7.3. Drug Estimates By Type
  • 15.2.2.7.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.2.7.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.2.8. Norway
  • 15.2.2.8.1. Drug Insights
  • 15.2.2.8.2. Drug Estimates By Route of Administration
  • 15.2.2.8.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.2.8.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.2.8.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.2.8.3. Drug Estimates By Type
  • 15.2.2.8.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.2.8.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.2.9. Rest of Europe
  • 15.2.2.9.1. Drug Insights
  • 15.2.2.9.2. Drug Estimates By Route of Administration
  • 15.2.2.9.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.2.9.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.2.9.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.2.9.3. Drug Estimates By Type
  • 15.2.2.9.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.2.9.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.3. Asia Pacific
  • 15.2.3.1. Japan
  • 15.2.3.1.1. Drug Insights
  • 15.2.3.1.2. Drug Estimates By Route of Administration
  • 15.2.3.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.3.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.3.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.3.1.3. Drug Estimates By Type
  • 15.2.3.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.3.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.3.2. China
  • 15.2.3.2.1. Drug Insights
  • 15.2.3.2.2. Drug Estimates By Route of Administration
  • 15.2.3.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.3.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.3.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.3.2.3. Drug Estimates By Type
  • 15.2.3.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.3.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.3.3. India
  • 15.2.3.3.1. Drug Insights
  • 15.2.3.3.2. Drug Estimates By Route of Administration
  • 15.2.3.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.3.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.3.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.3.3.3. Drug Estimates By Type
  • 15.2.3.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.3.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.3.4. South Korea
  • 15.2.3.4.1. Drug Insights
  • 15.2.3.4.2. Drug Estimates By Route of Administration
  • 15.2.3.4.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.3.4.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.3.4.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.3.4.3. Drug Estimates By Type
  • 15.2.3.4.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.3.4.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.3.5. Australia
  • 15.2.3.5.1. Drug Insights
  • 15.2.3.5.2. Drug Estimates By Route of Administration
  • 15.2.3.5.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.3.5.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.3.5.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.3.5.3. Drug Estimates By Type
  • 15.2.3.5.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.3.5.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.3.6. Thailand
  • 15.2.3.6.1. Drug Insights
  • 15.2.3.6.2. Drug Estimates By Route of Administration
  • 15.2.3.6.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.3.6.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.3.6.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.3.6.3. Drug Estimates By Type
  • 15.2.3.6.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.3.6.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.3.7. Rest of APAC
  • 15.2.3.7.1. Drug Insights
  • 15.2.3.7.2. Drug Estimates By Route of Administration
  • 15.2.3.7.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.3.7.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.3.7.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.3.7.3. Drug Estimates By Type
  • 15.2.3.7.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.3.7.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.4. Latin America
  • 15.2.4.1. Brazil
  • 15.2.4.1.1. Drug Insights
  • 15.2.4.1.2. Drug Estimates By Route of Administration
  • 15.2.4.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.4.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.4.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.4.1.3. Drug Estimates By Type
  • 15.2.4.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.4.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.4.2. Argentina
  • 15.2.4.2.1. Drug Insights
  • 15.2.4.2.2. Drug Estimates By Route of Administration
  • 15.2.4.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.4.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.4.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.4.2.3. Drug Estimates By Type
  • 15.2.4.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.4.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.4.3. Rest of Latin America
  • 15.2.4.3.1. Drug Insights
  • 15.2.4.3.2. Drug Estimates By Route of Administration
  • 15.2.4.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.4.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.4.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.4.3.3. Drug Estimates By Type
  • 15.2.4.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.4.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.5. Middle East & Africa
  • 15.2.5.1. Saudi Arabia
  • 15.2.5.1.1. Drug Insights
  • 15.2.5.1.2. Drug Estimates By Route of Administration
  • 15.2.5.1.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.5.1.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.5.1.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.5.1.3. Drug Estimates By Type
  • 15.2.5.1.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.5.1.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.5.2. UAE
  • 15.2.5.2.1. Drug Insights
  • 15.2.5.2.2. Drug Estimates By Route of Administration
  • 15.2.5.2.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.5.2.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.5.2.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.5.2.3. Drug Estimates By Type
  • 15.2.5.2.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.5.2.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.5.3. Kuwait
  • 15.2.5.3.1. Drug Insights
  • 15.2.5.3.2. Drug Estimates By Route of Administration
  • 15.2.5.3.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.5.3.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.5.3.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.5.3.3. Drug Estimates By Type
  • 15.2.5.3.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.5.3.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.5.4. Rest of Middle East & Africa
  • 15.2.5.4.1. Drug Insights
  • 15.2.5.4.2. Drug Estimates By Route of Administration
  • 15.2.5.4.2.1. Oral Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.5.4.2.2. Injectable Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.5.4.2.3. Others Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.5.4.3. Drug Estimates By Type
  • 15.2.5.4.3.1. Branded Drug Estimates & Forecast 2021-2033 (USD Mn)
  • 15.2.5.4.3.2. Generic Drug Estimates & Forecast 2021-2033 (USD Mn)

Chapter 16. Innovations & Pipeline Scenario

Chapter 17. Competition Mapping

  • 17.1. Company Market Share (2025)
  • 17.2. Drug Revenue share (2025 & 2033)

Chapter 18. Gastric Cancer Drugs Market Share, By Region 2025 & 2033

Chapter 19. Conclusion



What questions do you have? Get quick response from our industry experts. Request a Free Consultation
ISO 9001:2015 & 27001:2022 Certified

ISO 9001:2015 & 27001:2022 Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

Trusted market insights - try a free sample

See how our reports are structured and why industry leaders rely on Grand View Research. Get a free sample or ask us to tailor this report to your needs.

Customize This Report
logo
GDPR & CCPA Compliant
logo
ISO 9001 Certified
logo
ISO 27001 Certified
logo
ESOMAR Member
Grand View Research is trusted by industry leaders worldwide
client logo
client logo
client logo
client logo
client logo
client logo